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A Model for Calculating Return on Educational Value in the Pharmaceutical Industry
Jennifer-Anne Momy
There is a need to further understand the value of continuing health education
(CHE) and its effectiveness. Physicians report spending, on average 50 hours per year
in CHE activities geared toward improving their performance and/or optimizing the
outcomes of their patients (Davis, O'Brien, Freemantle, Wolf, Mazmanian, & Taylor-
Vaisey, 1 999). Despite this investment, studies have demonstrated a lack of effect on
physicians' performance of current practice guidelines or gaps between real and ideal
performance.
The findings of this study demonstrate that changes beyond knowledge transfer
can occur as a result of didactic peer led group education despite barriers to application.
The results of this research also illustrate the need to further investigate six key areas
relating to measuring the return of CHE interventions within the pharmaceutical
industry: 1) the evaluation of multiple CHE activities/interventions implemented as a
concerted effort over time 2) the importance of clear identification of the types of
practice changes and patient outcomes that are being targeted by CHE programs 3) the
implementation of validated behavior and/or practice change instruments within CHE
program assessment 4) a better understanding of the role that barriers to change play in
the effectiveness of CHE programs 5) a better understanding of inter-disciplinary/inter-
professional education and the specific needs associated with this type of educational
iv
intervention with regards to program design and implementation 6) the continuous
refinement of models for calculating gains or losses from educational programs in an
aim to consistently demonstrate the value of CHE within provider organizations.
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1CHAPTER 1
INTRODUCTION
This research thesis includes a review and critical synthesis of literature relevant
to retum-on-investment (ROI) and continuing health education (CHE). Through an
empirical investigation into calculating return on educational value in the
pharmaceutical industry, this research contributes to the overall knowledge of return-on-
education modeling in a new and under-studied market. In addition, this research
presents insight into the potential of a new model for assessing value of investment into
educational initiatives worthy of consideration by academics, the medical profession,
industry professionals, and other key stakeholders.
Education, in its broad sense, refers to any act or experience that has a formative
effect on the mind, character, or physical ability of an individual. ..in its technical sense
education is the process by which society, through schools, colleges, universities, and
other institutions, deliberately transmits its cultural heritage-its accumulated
knowledge, values, and skills-from one generation to another (Kneller, 1971).
Physicians in Canada must undergo extensive formal education in order to
become licensed to practice medicine. In medicine there is a need for continuing the
process of education in order to maintain a high standard of patient care. Researchers in
the area of CHE have focused on the determining the effectiveness of CHE methods and
processes. Controversy has emerged as the source and funding of CHE activities,
particularly those originating from the pharmaceutical industry, being offered to
physicians has come into question.
2There were 63,682 physicians in Canada in 2007 (CIHI, 2008). In order to
practice medicine in Canada, a physician trained in Canada or in another country
requires an acceptable undergraduate Medical Doctor (MD) degree. All Canadian
medical graduates must complete an accredited postgraduate training program in order
to be eligible to take the certification exams. Each province/territory is responsible for
the regulation of the practice of medicine in their respective jurisdiction. Canadian
certification in Family Medicine is provided through the College of Family Physicians
of Canada. Certification in other specialties is provided by the Royal College of
Physicians and Surgeons of Canada. Upon completion of residency training, Family
Physicians must pass the College of Family Physicians of Canada Certification Exam
and other Specialists must pass the Royal College of Physicians and Surgeons of
Canada Certification Exam specific to their specialty. In Québec, attestation in Family
medicine or certification in another specialty is provided through the Collège des
médecins du Québec (IMG-Canada, 2008).
The College of Family Physicians of Canada (CFPC) is a national voluntary
organization of family physicians that makes continuing medical education of its
members mandatory. The College strives to improve the health of Canadians by
promoting high standards of medical education and care in family practice, by
contributing to public understanding of healthful living, by supporting ready access to
family physician services, and by encouraging research and disseminating knowledge
about family medicine (CFPC, 2008). There are approximately 20,400 members of the
CFPC and members qualify for designations which signify to patients and peers that
3high standards for training have been met and the member is committed to lifelong
learning.
Canadian physicians rely on translation of knowledge acquired through
education to effectively care for patients. Maintenance and continuously updating this
knowledge is done through a formal system of continuing health education (CHE).
Continuing medical education (CME) is defined as "educational activities that serve to
maintain, develop, or increase the knowledge, skills, performance, and relationships a
physician uses to provide services for patients, the public, or the profession"
(Marinopoulos, Dormán, Ratanawongsa, Wilson, Ashar , Magaziner, Miller, Thomas,
Prokopowicz, Qayyum & Bass, 2007, p.l). Sources of CHE include self-learning,
professional associations, universities, and provincial healthcare bodies. Over recent
decades, medical schools and teaching hospitals have become increasingly dependent on
industry support of their core educational missions (AAMC, 2008). Pharmaceutical
companies now support a significant amount of continuing medical education, medical
conferences and meetings of professional associations (Relman, 2001).
There is a need to further understand the value of CHE and the effects of
sponsorship on its effectiveness. Physicians report spending, on average (and among
other activities), 50 hours per year in CME activities, ostensibly geared toward
improving their performance and/or optimizing the outcomes of their patients (Davis et
al., 1999). Furthermore, a great deal of time and effort is dedicated to develop, accredit,
and implement CHE activities. Despite this investment, studies have demonstrated a
lack of effect on physicians' performance of current practice guidelines or sizable gaps
between real and ideal performance (Davis et al., 1999).
4This research thesis builds on the existing body of knowledge on the
effectiveness of CHE and further extending them to the Canadian context. Findings
complement existing literature on return-on-investment models and it provides a good
starting point for future research designed to measure the effectiveness of CHE
activities. This research proposes a Return on Educational Value Model for CHE
offerings that was piloted within a Canadian subsidiary of an International
pharmaceutical company and provides reliable and valid information about the impact
of a CHE program using the Dixon multilevel evaluation model. Finally, factors that
contribute to a successful CHE activity are identified.
This report consists of 5 chapters. Included in this study are a detailed literature
review, research hypotheses, methodology, analyses & results, and a discussion
including implications and recommendations for future research.
5CHAPTER 2
LITERATURE REVIEW
2.1 Return-on-Investment in Education
The outcomes associated with education have been researched extensively.
Societal benefits of higher education have been studied by governments who have a
vested interest in ensuring that the investment in educational programs is associated
with positive outcomes in productivity. For example, recent research shows that the
returns to investment in skills upgrading of less educated workers (in Canada) are three
times as great as for investment in physical capital (CPRN, 2006).
The measurement of retum-on-investment (ROI) is a financial exercise. Two
common formulas include the Benefit/Cost Ratio (BCR) and ROI (Philips, 2003):
BCR = Program Benefits
Program Costs
ROI (%) = Net Program Benefits ? 1 00
Program Costs
The BCR utilizes the total benefits and costs. In the ROI formula, the costs are
subtracted from the total benefits to produce net benefits which are then divided by the
costs.
While the exercise of measuring the ROI of a given activity is a relatively
straightforward exercise, it remains challenging to identify valid and reliable evaluation
metrics associated with the 'benefits' and 'costs' used in the model. Moreover, the
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Figure 2.1: ROI Model. From Phillips, JJ. (2003). Return on Investment in Training
and Performance Improvement Programs (2nd ed.) p.42. New York, NY. Butterworth-
Heinemann.
Philips (2003) suggests that the calculation of return on investment of an
educational activity may be simplified with the basic model illustrated above. The
model implies that the process should follow a sequence based in the collection of
meaningful data and the conversion of such data in to monetary values.
2.2 Effectiveness of Continuing Health Education
Thus far, very little has been done to "comprehensively and systematically
synthesize evidence regarding the effectiveness of CHE and the comparative
effectiveness of differing instructional designs for CHE in terms of impact on
knowledge, attitudes, skills, practice behavior, and clinical practice outcomes"
(Marinopoulos et al., 2007, ? 1). This form of continuing education is highly variable,
ranging from passive, didactic, large-group presentations to highly interactive learning
methods, such as workshops, small groups, and individualized training sessions.
7Examples of such educational activities include rounds, educational meetings,
conferences, refresher courses, programs, seminars, lectures, workshops, and symposia
(Davis et al., 1999).
The dissemination of educational materials alone (e.g. newsletters, clinical guidelines,
and audiovisual materials) is used commonly as a behavior change strategy, although
this approach has been shown repeatedly to be ineffective as a stand-alone intervention
(Pearson, Ross-Degnan, Payson, & Soumerai, 2003; Soumerai, McLaughlin & Avorn,
1989). One-to-one educational outreach has been shown to be an effective technique to
change physician behavior, and one-to-one education sessions delivered by peer leaders
have been demonstrated to increase guideline adherence (Simon, 2000). Group
education relies on either didactic or problem based approaches to influence behavior
(Soumerai et al., 1989). Research suggests that peer led education in small practice-
based groups was effective in transferring knowledge but was not effective in modifying
behaviour (Lu, Ross-Degnan, Soumerai, & Pearson, 2008). As Davis et al. assert,
"numerous questions remain regarding the effectiveness of formal CHE, including
group size, the role of the learning and practice environment, the clinical dimensions of
care, the assessment of learner needs, and barriers to change..." (Davis et al. 1999
p.873).
2.3 Evaluation Models in Continuing Health Education
Evaluation in continuing health education (CHE) is a traditional part of planning
but is often not approached with the same level of sophistication as other parts of the
teaching/learning transaction (Bennett, Easterling, Friedmann, Green, Koeppen,
Mazmanian, & Waxman, 1997). Those in CHE have tended to use formative evaluation
8to look at a program during its presentation for midcourse corrections and summative
evaluation to assess the course on its completion. While using objectives or goals as the
organizing principle for a model of evaluation is a simple concept that practitioners find
helpful, other authors recommend moving beyond objectives to a variety of other
organizing principles (Bennett et al., 1997).
2.3.1 Evaluation Models
A variety of evaluation models have been designed and developed in the aim to
clearly measure the impact and outcomes of educational interventions. Stake (1 950) and
Tyler (1975) both emphasized the importance of objectives as the basic premise for
evaluation. The strength of an objectives evaluation design is the explicit link between
what teachers intend to provide and what learners gain (Bennett et al., 1997). Scriven
(1973) proposed using formative evaluation within the planning group to provide
feedback on the curriculum development and summative evaluation outside of the
planning group in order to evaluate the product. Stufflebeam (1973) rejected the use of
objectives and focused on decision making as the central theme in evaluation. The CIPP
(context, input, process, and product) model defines and applies descriptive and
judgmental information about the worth of a project as described by its goals, structure,
process and product (Stufflebeam, 1973). However, these models do not help to
demonstrate actual changes in behavior or practices as a result of an intervention.
2.3.2 Quantitative vs. Qualitative Evaluation Designs
Quantitative evaluation produces demonstrable, confirmable, and reproducible
results. However, those in CHE have not always found quantitative evaluation to
provide results that have been helpful in answering some of the most important
9questions in the field about how and when physicians change behavior. The classic
research design in medicine is the randomized control trial (RCT). Noted for its rigor
and robust results given tightly controlled parameters, RCTs have been held up as the
hallmark as strong science (Bennett et al., 1997). The fundamental challenge with this
model is its appropriateness for evaluating areas that cannot be controlled. In fields such
as the social sciences, qualitative designs have a rich and long history (Bennett et al.,
1997).
Qualitative evaluation addresses the importance of beliefs, reflection and
differences among individuals and groups (Davis et al., 2003). The dilemma is how to
create a design that is rigorous, relevant and practical; provide useful information to
learners, teachers and planners; and has value to the CHE community and others outside
the field (Guba and Lincoln, 1981). For this reason, Greene (1994) proposed a mixed
evaluation design drawing on both quantitative and qualitative evaluations.
2.3.3 Evaluation Schemas
Other authors have proposed using evaluation schémas or levels of learning.
Kirkpatrick (1 998) proposed four levels of learning designed primarily for on the job
training: reaction, learning, behavior and results. Phillips built on the Kirkpatrick model
by proposing five levels: reaction and planned action, learning, job applications,
business results and return on investment. Dixon's levels of evaluation, satisfaction
(perception), learning (knowledge and attitudes), performance (professional behaviors in
actual clinical practice) and patient status (impact on patient status), were derived from
other fields but adapted specifically for the health care field (Davis et al., 2003). Dixon's
levels have been particularly helpful in moving beyond participants perceptions of a
io
course. Mazmanian et al. suggested a model much like Dixon's except that each stage
was cumulative and progressive (Davis et al., 2003). Fox proposed a discrepancy
analysis model for evaluation specific to CHE activities (Davis et al., 2003). The Fox
model is characterized by three stages: 1) establish standards for acceptable patient
health status 2) define physician performance and competence and 3) define and
measure the discrepancy (Davis et al., 2003). Schema evaluation designs push the
developer and CHE provider to think about different levels of evaluation and the need to
use different instruments to measure each of these effectively.
2.4 The Canadian Continuing Health Education System
Physicians are ethically bound to maintain competence in their field as part of
their professional accountability to the public (Levinson, 2008). The Canadian Medical
Association's Code of Ethics says it is the responsibility of physicians "to engage in
lifelong learning to maintain and improve their professional knowledge, skills and
attitudes." (CMA, 2009, http://policybase.crna.ca/PolicvPDF/PD04-06.pdf.).
Continuing health education (CHE) or continuing medical education (CME)
consists of educational activities which serve to maintain, develop, or increase the
knowledge, skills, and professional performance and relationships that a physician uses
to provide services for patients, the public, or the profession (Davis et al., 2.003). It
represents the final and often most poorly understood stage of physician education
(Amin, 2000). This is because although CHE activities typically provide physicians with
a certain number of credits towards maintaining their practice license and ensuring that
this group of health care professionals keep up to date on new developments within their
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profession (Tian, Atkinson, Portnoy & Gold, 2007), it is practiced in an independent and
self-directed fashion with little direction and regulation by governing bodies.
This educational context requires physicians to be able to self-assess their
abilities and choose learning activities that address gaps in performance. However,
several recent studies have questioned whether physicians can accurately assess their
own abilities (Davis, Mazmanian, Thorpe & Perder, 2006; Silver, Campbell, Marlow,
Sargeant, 2008). In fact, a recent review by Davis et al. demonstrated that physicians are
not very accurate when assessing their abilities, specifically when compared to objective
external measures and benchmarks (2006). Employing feedback mechanisms and or
self-audits to enable physicians to identify learning gaps, provide cues to increase
educational awareness and further knowledge and skills can help to improve physician's
performance and enhance patient outcomes (Davis et al., 2006; Silver et al., 2008).
The field of CHE has struggled with evaluating the effectiveness of its programs
events and activities. The primary issue is that although physicians report investing a
significant amount of time completing CHE programs every year, studies show a
considerable difference between real and ideal performance (Davis & Taylor-Vai sey,
1997). This suggests a lack of effectiveness of formal CHE. Some have argued that
traditional continuing health education has been disconnected from the actual practice of
medicine and has not focused on providing the most useful information in the most
effective way (Ebell & Shaughnessy, 2003). While others have found some evidence
that highly interactive sessions that provide the opportunity to practice and reinforce
skills can result in a change in practice and on occasion health care outcomes (Davis et
12
al., 1999). More recently, Davis argued that changing health care outcomes requires
multiple educational interventions including formal CHE activity followed up by small-
group interventions as well as a concerted effort in providing effective patient education
(Davis et al., 2006).
Demonstrating outcomes of CHE efforts and resources has become more and
more important for CHE providers due to increased concerns about both the quality and
cost of healthcare (Davis et al., 2003). In the field of CHE an outcome can be
understood as the result or consequence of an educational activity or program. However,
the nature of the terms "outcome," or "result," in the complexity of health care and the
health education environment presents a great challenge (Gilman, Cullen & Leist,
2002). For CHE providers, accrediting organizations, as well as licensing bodies the
main challenge is defining the nature of the outcomes for which they are responsible
(Gilman et al., 2002). There does not seem to be clear and consistent expectations from
these groups on the impact of continuing health education programs and events.
In an effort to facilitate the assessment of physician learning and practice change
Dixon proposed a multilevel evaluation model specifically designed for CHE activities.
Dixon described four levels of evaluation of CHE for health professionals: "satisfaction,
learning, performance, and patient health status" (Davis et al., 2003, p.250). This model
was adapted from Kirkpatrick's four levels evaluation model that is used in business and
industry. The levels constitute an approach to assessing the effectiveness of an
educational activity or program in meeting its goals for each specific level (Davis et al.,
2003).
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Those in the human resource and training field have also suggested that a return
on investment (ROI) component to account for costs be incorporated into Dixon's
multilevel evaluation model for each stage (Phillips, 2003). The challenge with this
approach is that integrating an ROI benefit-cost analysis at each level assumes that
every educational activity will progress through all stages. The reality is that not all
CHE activities will pass through all levels (Davis et al., 2003). Therefore the
Kirkpatrick-Phillips model has been challenged within the CHE field. To effectively
demonstrate the outcomes of CHE efforts Davis et. al. (2003) argues that CHE
evaluation should focus on identifying, measuring, and describing the value provided by
a program or activity. The value of a program or activity can be similar to the four levels
such as satisfaction, learning, performance, patient health, or it can account for
additional benefits such as better image, increased referrals, etc. Therefore the most
important first step for all CHE providers in demonstrating outcomes is first defining
"value". Adopting a model which identifies the major domains of valued outcomes for
CHE interventions seems useful and practical for some CHE providers (Gilman et al.,
2002). This helps to either assess a single activity's outcomes or to assess a CHE
provider's overall outcomes (Gilman et al., 2002). Additionally, this approach can link
together the provider's organizational objectives, the assessment of the overall program
as well as the specific activity assessment (Gilman et al., 2002).
2.5 The Canadian Pharmaceutical Industry
The Canadian pharmaceutical industry measured through Canadian retail and
hospital purchases grew at a +6.3% (or $1 .12 billion) in 2007, totaling $18.98 billion in
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Figure 2.2: Total Canadian Pharmaceutical Industry Purchases in 2007. From IMS
Health.Canadian Drug Stores and Hospital Purchases. IMS Health Canada. December
2007.
Canada's research-based pharmaceutical companies (Rx&D) is the national
association representing 50 research-based pharmaceutical companies in Canada.
Member companies share a single primary objective: to discover new medicines that
improve the quality of health care available for every Canadian (Rx&D, 2009)
In addition to working towards discovering and developing innovative
medicines, Canadian pharmaceutical companies engage in promotional activities
designed to stimulate demand for marketed products. Drug promotion can be defined
as all informational and persuasive activities by manufacturers and distributors, the
effect of which is to induce the prescription, supply, purchase and/or use of medicinal
drugs (World Health Organization, 1998).
The most common forms of pharmaceutical promotion are representative
detailing, journal advertising, and sampling. In 2007 the IMS Health Canada Canadian
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Promotion Audit (CPA) measured the promotional efforts of pharmaceutical
manufacturers by reporting on sales calls made by company representatives to a sample
of Canadian physicians and by tracking journal advertising placements and
expenditures. Results of this audit demonstrated that there was approximately CDN
$63,756,000 invested in journal advertising to promote prescription medications to
Canadian physicians, and 3,218,000 individual details of prescription medications to
individual Canadian physicians. An estimated 23,036,000 samples were distributed to
physicians in Canada (IMS, 2007).
Information on the product detailing efforts ofpharmaceutical representatives is
collected each month from 642 office-based physicians, stratified by region and
specialty, who record representative calls on a secure website or via hardcopy diaries
(IMS, 2007). The information is coded and processed and then projected to provide a
national estimate. To collect advertising spending information IMS conducts a monthly
audit of ads placed in over 88 journals. The journals represent virtually all medical
publications in Canada, including general, specialty, pharmacy, nursing hospital and
dental journals. Canadian Advertising Rates Data serve as the basis for estimating ad
placement expenditures.
2.6 The Canadian Pharmaceutical Industry Involvement in Continuing Health Education
In addition to Pharmaceutical company's efforts to discover new medicines and
promote them to physicians, there is a considerable investment in continuing health
education initiatives.
The pharmaceutical industry has long been a major sponsor of educational programs for
doctors and health care professionals alike. A recent Canadian Medical Association
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Journal (CMAJ) editorial which received significant media attention noted that in 2006
US$2.6 billion were spent on continuing medical education for doctors in the United
States, of which US$1 .45 billion came from drug or device makers (Hebert, 2008). The
editorial stated corresponding figures for Canada are not available, but revealed there
was "no evidence that the situation is any different here" (Hebert, 2008, ? 178). This
particular editorial written by the CMAJ's editor-in-chief served to draw public attention
and raised questions about a topic long debated within the medical profession and the
pharmaceutical industry on the exact nature and impact of continuing health education
(CHE) and in particular those sponsored by pharmaceutical companies.
2.7 Key Parties Affected by the Effectiveness of Pharmaceutical Sponsored Continuing
Health Education
There are several parties affected by the effectiveness of pharmaceutical industry
sponsored continuing health education. While it is logical to assume that all
stakeholders are concerned with the successful transfer or knowledge and the
subsequent optimization of patient care, there are other factors being used in assessing
the effectiveness of CHE investments. In particular, concerns have been raised by
critics of the impact of pharmaceutical manufacturer sponsorship on the effectiveness of
CHE activities, and manufacturers themselves must reconcile the importance of
adhering to educational principles with the need to deliver shareholder value in the
investments being made.
Industry sponsored CHE initiatives may prove beneficial in that it allocates
significant funding to developing and maintaining professional competencies in
17
Canadian healthcare professionals. However, the rational for investment into CHE and
the subsequent financial transactions involved in delivering of CHE may offset some of
the proposed benefits by potentially introducing bias into the process and thus
influencing participants (Davis et al., 1999).
It is useful to briefly address some of the parties potentially affected by the
effectiveness of industry sponsored CHE to bring the importance ofproper measurement
of effectiveness into context.
2. 7.1 CHE and the Canadian Government
The Canadian Government has a significant interest in ensuring that Canadian
healthcare professionals are adequately trained and are able to deliver safe and effective
healthcare to patients. The Canadian government does not currently regulate the
continuing education of physicians and relies on professional associations such as the
College of Family Physicians of Canada to oversee CHE content offered for educational
credit.
2. 7.2 CHE and Patients & Public
The Canadian public including, patients who present for healthcare have a vested
interest in ensuring that the Canadian medical profession offers optimal care. Canadians
are frequently exposed to media attention to the role of the pharmaceutical industry in
the healthcare system, and the possibility that this involvement may influence the
quality of patient care by favoring sponsor medicines and services.
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2. 7.3 CHE and Pharmaceutical Manufacturers
The pharmaceutical industry in Canada has been a major contributor to
innovative, ethically conducted, continuing education programs and health education
research. At the CACHE (Canadian Association of Continuing Health Education)
meetings in 2002 and 2003, of 1 55 abstracts that passed a rigorous peer-review process
and were accepted for presentation, 63 had authors or co-authors who worked for
industry (Marlow, 2004).
There is evidence that the pharmaceutical industry can influence physician
prescribing through marketing and educational efforts, (Bowman 1986, 1988a; Wazana,
2000; Wolfe, 1996). Furthermore, grants or other unrestricted forms of funds made
available from pharmaceutical manufacturers may focus on programs that cover an area
of commercial interest.
Pharmaceutical manufacturers have an interest in ensuring the effectiveness of
their continuing health education initiatives to promote advances in medicine and to
deliver shareholder value. Member companies to Canada's Rx&D are required to
adhere to the Code of Marketing Practices of Rx&D which in discussing industry
sponsorship of CHE, states that "member companies will: support, where possible, the
principles and practices of CHE [continuing health education] programs established by
practitioner bodies." (Rx&D, 2009 http://www.
canadapharma.org/About_RxD/Overview/index_e.html)
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Critics of pharmaceutical manufactures' role in CHE have suggested that "If
drug companies' primary motivation for contributing to CME is to advance physicians'
knowledge, then they should heartily embrace a system whereby they place their money
into a blind trust from which independent parties organizing CME events would be able
to draw" (Lexchin, 2007 pi 61 .)·
2. 7.4 CHE and Public & Private Health Reimbursement Bodies
Public & Private Health Reimbursement Bodies are largely responsible for
payment of medical services and treatments offered to Canadians. Payers must estimate
the costs associated with delivering a desired level of care based on a variety of factors
including population demographics, epidemiology, and cost & availability of resources
including healthcare professionals and medicines. The role of education in managing
the demand for limited healthcare resources is an important consideration for
reimbursement bodies and consequently industry involvement in continuing health
education is a potential concern, particularly where initiatives undertaken by industry
are inconsistent with payer initiated programs
2. 7.5 CHE and Physicians
The costs of CHE are significant. Typically, participating Physicians must not
only pay for the course and the costs of attending, but must continue to pay office
overhead and lose income during their absences. In Canada, unlike other professionals,
physicians are not able to defer costs to patients in the form of higher fees. It has been
speculated that if restrictions on financing CHE are introduced that tuition fees for
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quality educational offerings will increase, adding to the burden on physicians (Marlow,
2004).
Industry support for CHE affects academic providers of CHE. A recent editorial
in the Journal of Continuing Education in the Health Professions (Mazmanian, 2009,
vol. 28(3), p. 134) indicated that a recent estimate suggests 4,01 3 dollars was spent per
physician in 2007 on CHE activities designated for American Medical Association
Category 1 credit. Universities often receive substantial industry support for their CHE
activities: in 2005, CHE activities originating in US schools of medicine received 60%
of their total income from industry, up from 43% 5 years earlier (ACCME, 2007).
Full disclosure is the latest response to concern about financial conflicts of
interest and the propriety of various associations between medicine and industry.
Advantages of industry funding, such as the support of drug and device development
and pivotal clinical trials, must be balanced against the disadvantages, such as the
potential for influencing prescribing and use ofmedical devices and supplies, increasing
the costs of care, fostering a mindset of entitlement among doctors, and undermining the
independence and integrity of the profession (Steinbrook, 2008).
For example, when the Cleveland Clinic and some of its leading physicians were
criticized for their financial associations with industry and the limited disclosure of
these relationships to patients and the public specific actions were taken to rectify this
situation. In response, the medical center strengthened its policies and oversight with
regard to conflicts of interest and required that all industry relationships be submitted for
approval. Since December 2008, it has also disclosed on its Web site
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(www.clevelandclinic.org) some of the industry ties of its 2000 physicians and
researchers and their immediate families (Abelson, 2008).
Other measures to limit the potential for bias in education resulting from
industry sponsorship have been proposed including sensitizing individual doctors to
minimize their exposure to potentially biased information by avoiding programs that are
heavily subsidized by one company (Steinman, 2007).
2.8 The Need for a Model for Calculating Return on Educational Value in the
Pharmaceutical Industry
The need for continuing health education coupled with the recent media
attention, significant investment required and competing interests of stakeholder's
warrants further investigation into a model to measure the value of these activities. The
field of CHE represents the final and often most poorly understood stage of physician
education (Amin, 2000). The educational context requires physicians to be able to self-
assess their abilities and choose learning activities that address gaps in performance.
While there exist a variety of continuing education methods the didactic method
continues to be the most popular means of delivering industry sponsored CHE. The
reasons for the persistence of didactic CME include the ease of designing and providing
such activities, the substantial pharmaceutical sponsorship that promotes the transfer of
information about new medications, and the dependence on traditional undergraduate





The objective of this study is to develop and assess a model that will help
determine the Return on Educational Value for CHE within the pharmaceutical industry
context.
This work is addressed to CHE providers and generally to people who are
introducing outcome measures into CHE programs and/or activities. For this reason, the
aim of this study is to a) develop and pilot a Return on Educational Value Model for
CHE offerings within a Canadian subsidiary of an International pharmaceutical
company, b) provide reliable and valid information about the impact of a specific CHE
program using the Dixon multilevel evaluation model (satisfaction, learning,
performance and patient health) and c) identify factors that contribute to a successful
CHE activity.
3.2 Sample and site
This research focused on Health Care Professionals (Specialists, Family
Physicians, Nurses, Pharmacists & Case workers) who attended a specific educational
activity in the HIV therapeutic field. Some Health Care Professionals worked in a
private clinic setting and others in a hospital setting, while some worked in both
settings. Some subjects worked in a team setting while others worked in an independent
private practice. Subjects had different levels of experience and expertise in their role.
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Subjects worked in different geographic areas as well as types of locations (i.e. urban,
rural).
The educational activities took place at various sites and cities throughout
Canada. Some activities took place in the subjects' own professional setting (i.e. in a
clinic or at hospital lunch time rounds) while others took place in a hotel conference
room or a private room in a restaurant.
3.3 Access and permissions
Consent forms provided abrief description of the study and emphasized the
confidentiality of participant responses. In addition, prior to completing the
questionnaires, all participants were verbally assured full confidentiality. Questionnaires
were identified by number codes rather than participant names (when names were
provided). The researcher maintained a list of participants' names (when provided) and
corresponding code numbers for the purpose of identifying participants for follow-up
interviews. Participants were not remunerated for completing questionnaires or
participating on the research project. All participants' identities remained anonymous
throughout the research project (see appendix 1). In clinical settings, access to the
various sites was obtained in advance of any program being implemented.
3.4 The Model
A model was developed which identified the major domains of valued outcomes
for the subsidiary of an international pharmaceutical company in order to measure the
impact of CHE programs on specific value targets. The value targets were defined based
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on three core principles consistent with the organization's overall value proposition as
well as the Dixon four levels of CHE for health professionals (including satisfaction,
learning, performance and patient health status). These value targets were as follows: 1)
Educational Value, 2) Sponsor Representative Interaction with Client, 3) and Perceived
Program Value and Impact on Practice and Patient Health. The aim of adopting a model
which identifies the major domains of valued outcomes for CHE interventions was to
help focus efforts on assessing the CHE provider's overall outcomes (Gilman, 2002) and
to link together the provider's organizational objectives, the assessment of the overall
program as well as the specific activity assessment (Gilman, 2002). Additionally, it was
intended to provide the organization with information on where CHE is contributing to
their overall customer value proposition.
Each value target or evaluation component of the model was assessed using
specifically designed pre and post-tests which are discussed in the Instruments and their
reliability and validity section.
Additionally, a scorecard was developed and incorporated into the model in
order to provide an overall program rating. The scorecard sections (Educational Value,
Sponsor Representative Interaction with Client, and Perceived Program Value and
Impact on Practice and Patient Health) were all evaluated using short user-friendly
questionnaires and guided interview. Variables from the questionnaires and interview
guide were weighted to according to the provider's corporate strategic priorities. The
scorecard provides an aggregate score compiled to provide a percent score indicating the
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success of the program according to these priorities. The scorecard is simply a concise
set ofmeasures and metrics that relate to the overall performance.
The table below summarizes each area that was assessed:
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post in addition to
the follow up guide
The details regarding the tools and techniques employed, method or procedure adopted
for collecting data and the statistical techniques employed for the analysis of data are
given below.
3.5 The program
The CHE program serving as an educational intervention was focused on the
area of HIV. The learning objectives were as follows:
At the end of the program, participants will be able to:
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- Understand the course of disease progression with
CCR5 vs. CXCR4 tropic viruses
- Review the latest evidence on new therapies for
treatment-experienced patients in HIV
- Describe the place of CCR5 antagonists in HIV management
- Apply clinical trial results to the management of
treatment-experienced patients in their practice
The program was case-based and centered on finding ways through new novel
therapies, to achieve maximal response in patients having previously received
antiretroviral therapy for HIV. The program proposed participants test for different
categories of resistance/cross-resistance and identify specific mutations in order to
choose appropriate treatments. The educational module discussed the place for the
various treatments according to guidelines and specific objectives of treatment. The
tests required in order to select and administer therapies were explained at length as
they were necessary to selecting any new therapies.
3.6 Method adopted
A pre-experimental research design was used for this study. A pre-test, post-test,
and structured follow up interview design were developed and implemented. The details
regarding the method / procedure adopted for collecting the data are given below under
appropriate sub-headings.
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3.7 Instruments and their reliability and validity
The following three instruments were developed to collect the necessary data
and measure outcomes in this research project:
(1) Pre-test CHE Event Questionnaire (appendix 1)
(2) Post-Test CHE Event Questionnaire (appendix 2)
(3) Follow up Interview Guide (appendix 3)
Validated data collection instruments and materials were not available in the
literature for this study's purposes and therefore they needed to be created. Both the
Kirkpatrick (1998) four levels for evaluating training programs and the Dixon (1978)
four levels and suggested strategies for evaluating continuing health education were
used as a basis for questionnaire design. All instruments were pilot tested with a small
group of the sponsor representatives before being implemented. This group had a good
understanding of the target audience's needs and provided feedback on the
questionnaires as a result. Appropriate preventative measures to account for any
response bias by participants were taken. Steps were also taken to ensure that the
questionnaires designed were simple, brief, and user-friendly with clear written and
verbal instructions for all participants.
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The details regarding the tools are given below.
(1) Pre-test CHE Event Questionnaire
The pre-test was designed to measure what the participants expect to gain by
participating in the CHE activity as it relates to the educational program's learning
objectives (importance of content), relevance to practice (knowledge and learning),
perceived impact on practice (performance/ application of knowledge) as well as the
program organization (factors which attracted participants to the program) before the
event. The pre-test consisted of fourteen structured and closed ended questions using the
likert 5-point scale to assess learning objectives from 1 (Very important) to 5 (Not
important), relevance to practice and program organization from 1 (Strongly Disagree)
to 5 (Strongly Agree) and perceived impact on practice from 1 (Very Much) to 5 (Not at
all) on participants' clinical practice (see appendix 2). In addition, the pre-test included
participant information and participant characteristic questions which were optional
sections for participants to complete. The pre-test was administered directly before each
CHE event with clearly written and verbal instructions from the program facilitator.
(2) The Post-test CHE Event Questionnaire
The post-test was designed to measure the participants experience in
participating in the educational event with much the same sets of questions in the pre-
test CHE Event Questionnaire (learning objectives, relevance to practice, perceived
impact on practice, program organization) with the exception of an additional section on
identifying barriers to implementing what participants have learned. The barriers to
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application section was incorporated directly into the post-test in order to identify any
potential threats to the impact of the CHE event up front and offer up any potential
explanations. The post-test consisted of twenty-five structured and closed ended
questions using the likert 5-point scale to assess learning objectives from 1 (Very
important) to 5 (Not important), relevance to practice and program organization from 1
(Strongly Disagree) to 5 (Strongly Agree) and perceived impact on practice from 1
(Very Much) to 5 (Not at all) (see appendix 2) and one open question where participants
were prompted to list any other barriers to implementing key elements from the program
into their everyday practice that were not addressed in the questionnaire. The post-test
was administered directly after each CHE event with clearly written and verbal
instructions from the program facilitator.
(3) The Follow-up Interview Guide
The follow up interview guide was designed as a structured questionnaire for
sponsor representatives to follow up with participants one month post CHE event to
collect feedback on the event and assess the impact of the CHE program as it relates to
the participants' reaction to the program (3 questions), perception of knowledge gain (1
question), views on relevance to practice (2 questions), intended and actual practice
change (6 questions), perception of impact on patient outcomes (1 question), perceived
value of the program (1 question), as well as any change in sponsor representative
interaction with client (2 questions). The follow up guide consisted of sixteen closed
ended questions using the likert 5-point scale to rate individual responses from 1 (Not at
all) to 5 (Very much) (see appendix 3). It included two additional open ended questions
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relating to any further assistance the sponsor representative could provide as an outcome
of the program and identifying the specific barriers that prevent the health care
professional from implementing what was learned. Both open ended questions were
included in order to help sponsor representatives clarify and further understand customer
needs. The follow up interview guide questions were also prioritized into three
categories: Must ask, Should ask, and Could ask ifhave time or interest. This was
incorporated into the guide (after pilot testing the questionnaire) as a preventative
measure to help representatives focus on core areas requiring responses for the purpose
of the study should participants have limited time to spend in the follow up interview.
3.8 Procedures of data collection
For this research project convenience sampling was used. Participants attending
accredited CHE events for a specific program in the HIV field were notified about the
associated research project by the program facilitator and asked to participate (prior to
each event a Sponsor Representative ensured that facilitators were properly briefed on
all materials associated with the research project). For those who accepted to participate,
the facilitator asked them to complete a pre-test and post-test for the educational
program at the beginning of the program (see appendix 2). The facilitator also notified
participants that a follow up structured interview one month later administered by the
sponsoring company representative would also occur upon their acceptance. The
facilitator highlighted the consent form which also had to be filled out in order to take
part in the research. Participants were notified that "the questionnaires are part of a
research project, for which details are covered in the manuals and that the pre-test and
post-test questionnaires are completely voluntary, anonymous and at each participants
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discretion to fill out, as is the follow up interview one month later". All participants
were asked to participate on a voluntary basis and consent forms were provided and
collected along with the pre-post questionnaires (see appendix 1).
Once questionnaires were completed on site, a company representative followed
up with participants on an individual basis one month later to conduct a structured
interview. The structured interview was designed to capture specific information
regarding the participants overall feedback on the program along with implications on
any changes in practice and potential changes in customer interactions. The interview
process was guided by closed questions with one or two opportunities to provide open
feedback. Interviews were conducted by the sponsor company representatives. The
interview was conducted one on one, in a private setting and the participant was verbally
assured that all responses were voluntary, confidential and kept completely anonymous.
All company representatives received opportunity for one or more (as many as they felt
necessary to feel comfortable) briefings on all processes and instruments related to this
research project as well as exactly how to conduct the structured interview and what
information had to be communicated regarding confidentiality. A list of verbal probes to
help guide the interview were provided to the representative directly on the
questionnaires. Questions were also identified according to their importance for the
interview process on the interview guide in order to ensure a minimum number of "must
ask" questions were answered (see appendix 3). Representatives collected and sent all
completed pre/ post questionnaires and follow up interview guides in to the Therapeutic
CHE Manager who was responsible for all data collection and analysis related to this
project.
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3.9 Analysis of the data
This research consisted of a single sample pre-experimental design. Data
collected included participant quantitative (pre-test & post-test) and qualitative (follow up
interview) measures. Quantitative data was collected in order to enable a single-group
pre-test post-test analysis of differences. Qualitative data, collected was expected to
provide some insight into differences between the pre-test & post-test results as well as
expand on the higher levels of the Dixon model and answer questions related to any
behavior change by using a semi-structured interview consisting ofboth open and closed
ended questions. At baseline, pre-test measures included some demographic
characteristics of participants. The post-test interview and additional qualitative
measures administered post-test were used to support the internal validity inferred in
differences in the pretest and post-test scores.
To compare the results for each question of the post-test to those of the pre-test
the Wilcox Sign test was selected. The data are ratings (ordinal data) and may not be
reasonably supposed to have a normal distribution therefore a non-parametric test was
appropriate. The Wilcox Sign test or Wilcoxon Signed-Rank test is a non-parametric
statistical comparison of the average of two dependent samples (StatSoft, 2009). It is
considered when samples are small and/ or the distributional assumptions necessary for
the t-test come into question.
The Wilcox Sign test is a test of dependency. All dependence tests assume that
the variables in the analysis can be split into independent and dependent variables. A
dependence test that compares the averages of an independent and a dependent variable
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assumes that differences in the average of the dependent variable are caused by the
independent variable (StatSoft, 2009).
The null hypothesis in this research concerns the identity of the two population
distributions and if the two population distributions are of even moderately similar shape
and variability.(StatSoft, 2009). A non-directional alternative hypothesis was selected for
this research as the investigator simply wanted to know if there is "a difference" between
the two scores in the pre and post test questions - and a difference in either direction is of
equal interest (StatSoft, 2009).
The mean, mode, median and standard deviation were also used to analyze the
scores for each question and histograms were used to represent mean scores for each
question of each section. The mean was also used to calculate average scores for each
question on the post program follow up interview along with any qualitative data




4.1 Descriptive analysis of all data
The descriptive details regarding all data are given below.
4.1.1 Sample and Participant information
This research focused on a variety of different types ofhealth care professionals
working in the field of HIV. Included in the sample were Specialists, Family Physicians,
Nurses, Pharmacists & Case workers. Convenience sampling was used for all health
care professionals participating in a continuing health education program sponsored by a
Canadian subsidiary of an international pharmaceutical company. In total 173 Health
Care Professionals participated in this research project through approximately 20
educational sessions run across Canada. Some activities took place in the subjects own
professional setting (i.e. in a clinic or at hospital lunch time rounds) while others took
place in a hotel conference room or a private room in a restaurant. A total of 173
participants completed the pre-test and post-test questionnaire and a total of 34 of the
same participants completed the follow up interview. Five additional interviews were
conducted however the structured interview process was not followed and the answers
were incomplete. Therefore these interviews were omitted from the results of this
research. Demographic information was optional for participants to supply and
consequently none of the participants completed this portion of the pre-test
questionnaire.




Follow up Interview 34



























































































































































































































































































































































importance of Learning Objective 1
Importance of Learning Objective 2
Importance of Learning Objective 3
Importance of Learning Objective 4
The topic of this program is highly relevant to my clinical practice
The topic of this program is unrelated to my practice
The knowledge I gained in attending this program will improve my
clinical practice
I have patients who will benefit from my increased knowledge about this
topic
To what extent do you think you will apply what you will learn in this
session to the treatment of your patients in your clinical practice
Have you considered how you will implement changes in your treatment
of patients following this program
How confident are you that you will apply what you will learn in this
program to the treatment of your patients
Lack of experts to consult with in applying new knowledge with my
patients
Lack of accessibility to follow up materials to reinforce my changing my
practice
Lack of necessary equipment to apply new knowledge gained
Lack of time to implement new practices
Lack of financial resources to implement new practices
Other barriers
Setting was appropriate for learning
Length of program was appropriate
Speaker was knowledgeable and was familiar with the content
Teaching materials, e.g. slides, handouts, were useful and appropriate
Program content was credible and unbiased
Information was presented clearly
Speaker was knowledgeable and was familiar with the content
Adequate opportunity was provided for interaction and questions with
the speaker and with other participants
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4.1.2 Pre-Test Questionnaire Descriptive Statistics
The pre-test questionnaire consisted of fourteen structured and closed ended
questions relating to the educational program's a) learning objectives (importance of
content), b) relevance to practice (knowledge and learning), c) perceived impact on
practice (performance/ application of knowledge in clinical practice with patients) as
well as d) the program organization. To measure participants' responses the likert 5-
point scale to assess from learning objectives from 1 (Very important) to 5 (Not
important), relevance to practice and program organization from 1 (Strongly Disagree)
to 5 (Strongly Agree) and perceived impact on practice from 1 (Very Much) to 5 (Not at
all) was used. A reverse scale was used for the perceived impact on practice in the pre-
test and the post-test questionnaires to check for response bias by participants.
Overall, the results from the pre-test questionnaire showed that participants rated
the program's learning objectives and topic as very important and very relevant to their
practices. Participants intended to apply what they learned in the program and were
confident that they would apply what they learned in the program to the treatment of
their patients. They were more or less sure however how they would implement changes
in their treatment of patients. Participants also strongly agreed that the setting and
length of the program were appropriate and the facilitator and/or key speaker was
credible as factors attracting them to the program. No trace of response bias was found
in the data through the reverse scaling of the pre and post questionnaires.
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The following table provides the mean scores, standard deviations, medians and
modes for each question in the pre-test questionnaire.






The topic of this program is highly relevant to my
clinical practice
The topic of this program is unrelated to my practice
The knowledge I gained in attending this program will
improve my clinical practice
Relevance to practice - 1 have patients who will benefit
from my increased knowledge about this topic
Standard Media Mod
Mean Score Deviation _n e
1
To what extent do you think you will apply what you
will learn in this session to the treatment of your
patients in your clinical practice
Have you considered how you will implement changes
in your treatment of patient following this program
How confident are you that you will apply what you will
learn in this program to the treatment of your patients
Setting would be appropriate for learning
Length of program would be appropriate
































a) Importance of Learning objectives
The learning objectives for this program were as follows: 1) Understand the
course of disease progression 2) Review the latest evidence on new therapies for
patients in HIV 3) Describe the place for certain treatments in HIV management and 4)
Apply clinical trial results to the management of patients. On a scale of 1 (Very
important) to 5 (Not important) overall participants overwhelmingly rated the learning
objectives in the pre-test as all being very important for their practice. The following
graph illustrates the distribution of scores in the pre-test for all four learning objectives
combined.
Distribution of Scores for Learning
Objectives
I m Frequency ;¡
12 3 4 5 More
Score
Figure 4.1: Distribution of Scores for Learning Objectives
In taking a closer look at the different learning objectives, the results show that
objective 2 and objective 3 were rated higher than objective 1 and objective 4. This
means that participants were most interested in reviewing the latest evidence on new
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Figure 4.2: Mean Score of Learning Objectives
b) Relevance to Practice
The results of the pre-test on the relevance of the program to the participants'
practices were measured from 1 (Strongly Disagree) to 5 (Strongly Agree). The findings
demonstrate that participants strongly agreed that that the topic was highly relevant to
their practices and that the knowledge gained would improve their practices.
Participants also agreed that ultimately this knowledge would benefit their patients. The













































Figure 4.3: Relevance to Practice Mean Scores
The answers in the pre-test relevance to practice section also confirmed the reliability of
the participants' answers as the second question in this section was reversed from the
first question to confirm that the topic was relevant to the participants' practices.
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Distibution of Relevance to Practice Scores
i s Frequency
More
Figure 4.4: Distribution of Relevance to Practice Scores
c) Perceived impact on practice
The perceived impact on practice was measured the extent to which participants
intended to apply knowledge from 1 (Very much) to 5 (Not at all). Overall the pre-test
scores demonstrate that participants intended to apply knowledge in their practices and
with their patients. However the distribution of scores highlights an uneven curve.
Distribution of Perceived Impact on Practice Scores
m Frequency
More
Figure 4.5: Distribution on Perceived Impact of Practice Scores
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The results of the pre-test perceived impact on practice showed that while participants
were very confident that they would apply what they learned in the treatment of patients
in their practices, they had more or less considered how they would implement any
changes in their treatment of patients following the program. The following graph shows
the mean scores for each pre-test question related to impact on practice.










To what extent do Have you How confident are
you think you will considered how you that you will
apply what you you will implement apply what you
will learn in this changes in your will learn in this
session to the treatment of program to the
treatment of your patients following treatment of your
patients in your this program patients
clinical practice
Figure 4.6: Perceived Impact on Practice Mean Scores
d) Program organization
The program organization section of the pre-test questionnaire was measured
from 1 (Strongly disagree) to 5 (Strongly agree) of factors that attracted participants to
the program. Overall participants strongly agreed that the setting, length of program
were appropriate and the facilitator and or key speaker was credible. The following
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graph demonstrates the overall satisfaction with the program organization on all the
aspects on the pre-test.













Figure 4.7: Distribution of Program Organization Scores
A closer look at the results shows that while all factors measured were highly important
in attracting participants to the program, the speaker was the most important factor.
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learing appropriate credible
Figure 4.8: Program Organization Mean Scores
Overall, the results from the pre-test questionnaire showed that participants rated
the program's learning objectives and topic as very important and very relevant to their
practices. Some learning objectives in the pre-test were more important than others to
their clinical practice. Participants also intended to apply what they learned in the
program in their practices and were very confident that they would do so, although they
were more or less sure how they would implement changes in the treatment of their
patients. All factors measured in the program organization proved important in
attracting participants to the event. The facilitator and/or key speaker however was rated
as the most important feature of all.
4.1.3 Post-Test Questionnaire Descriptive Statistics
The post-test consisted of twenty-five structured and mostly closed ended
questions using the likert 5-point scale designed to measure the participants experience
in participating in the educational event with much the same sets of questions in the pre-
test CHE Event Questionnaire. Eighteen questions were related to learning objectives
which were rated from 1 (Very important) to 5 (Not important), relevance to practice
and program organization which were rated from 1 (Strongly Disagree) to 5 (Strongly
Agree) and perceived impact on practice which were rated from 1 (Very Much) to 5
(Not at all).(see appendix T). Five additional questions related to the barriers or
obstacles participants might encounter in putting new knowledge into practice and an
additional open question where participants were prompted to list any other barriers to
implementing key elements from the program into their everyday practice that were not
addressed in the questionnaire. The post-test was administered directly after each CHE
event with clearly written and verbal instructions from the program facilitator.
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Overall, the results from the post-test questionnaire showed that participants
rated the program's learning objectives and topic as very important and very relevant to
their practices. Participants intended to apply what they learned in the program and
were confident that they would apply what they learned in the program to the treatment
of their patients. They were more or less sure however how they would implement
changes in their treatment of patients. Participants also strongly agreed that the setting
and length of the program were appropriate and the facilitator and/or key speaker was
credible as factors attracting them to the program.
The following table provides the mean scores, standard deviations, medians and modes
for each question in the post-test questionnaire.










Objective 2 1.25 0.56
Importance of Learning
Objective 3 1.30 0.52
Importance of Learning
Objective 4 1.38 0.52
The topic of this program is
highly relevant to my clinical
practice 4.56 0.70
The topic of this program is
unrelated to my practice 1.33 0.55
The knowledge I gained in
attending this program will
improve my clinical practice 4.27 0.84
I have patients who will benefit
from my increased knowledge
about this topic 3.99 0.70
To what extent do you think you
will apply what you will learn in
this session to the treatment of
your patients in your clinical
practice
Have you considered how you
will implement changes in your




How confident are you that you
will apply what you will learn in
this program to the treatment of
your patients 1.74 0.56
Lack of experts to consult with in
applying new knowledge with my
patients
Lack of accessibility to follow up






Lack of necessary equipment to
apply new knowledge gained
Lack of time to implement new
practices
Lack of financial resources to
implement new practices











Length of program was
appropriate
Speaker was knowledgeable and
was familiar with the content
Adequate opportunity was
provided for interaction and
questions with the speaker and
with other participants
Teaching materials, e.g. slides,
handouts, were useful and
appropriate




Speaker was knowledgeable and
was familiar with the content
Adequate opportunity was
provided for interaction and






















b) Importance of Learning objectives
The learning objectives for this program were as follows: 1) Understand the
course of disease progression 2) Review the latest evidence on new therapies for
patients in HIV 3) Describe the place for certain treatments in HIV management and 4)
Apply clinical trial results to the management of patients. On a scale of 1 (Very
important) to 5 (Not important) overall participants overwhelmingly rated the learning
objectives in the post-test as all being very important for their practice. The following
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graph illustrates the distribution of scores in the post-test for all four learning objectives
combined.










Figure 4.9: Distribution of Learning Objectives Scores
In taking a closer look at the different learning objectives, the mean scores
results show that objective 2 was rated as most important to participants' practices in the
post-test followed by learning objective 3, 1 and 4 respectively. This means that
participants post-event were most interested in reviewing the latest evidence on new
therapies for patients in HIV followed by describing the place for certain treatments in
HIV management, understanding the course of disease progression and applying clinical
trial results to the management of patients respectively.
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Learning Objectives Mean Scores
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Figure 4.10: Learning Objectives Mean Scores
b) Relevance to practice
The results of the post-test on the relevance of the program to the participants'
practices were measured from 1 (Strongly Disagree) to 5 (Strongly Agree). The findings
demonstrate that participants strongly agreed that that the topic was highly relevant to
their practices and that the knowledge gained would improve their practices.
Participants also agreed that ultimately this knowledge would benefit their patients. The
following graph illustrates the post-test mean scores of the program's relevance to
participants' clinical practices.
: B Mean öcore
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Relevance to Practice Mean Scores





























Figure 4.11: Relevance to Practice Mean Scores
The answers in the post-test relevance to practice section confirmed the reliability of the
participants' answers as the second question in this section was reversed from the first
question to confirm that the topic was relevant to the participants' practices.
Distribution of Relevance to Practice Scores
B Frequency
More
Figure 4.12: Distribution of Relevance to Practice Scores
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c) Perceived impact on practice
The perceived impact on practice was measured the extent to which participants
intended to apply knowledge from 1 (Very much) to 5 (Not at all). Overall the post-test
scores demonstrate that participants intended to apply knowledge in their practices and
with their patients. The distribution of the scores was skewed towards the participants
Very Much intending to apply new knowledge in their practices.




12 3 4 5 More
Figure 4.13: Distribution of Perceived Impact on Practice Scores
However, the results of the post-test mean scores of perceived impact on practice
showed that while participants post-event were confident that they would apply what
they learned in the treatment of patients in their practices, they still had more or less
considered how they would implement any changes in their treatment of patients
following the program. The following graph shows the mean scores for each post-test
question related to impact on practice.
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Figure 4.14: Perceived Impact on Practice Mean Scores
d) Program organization
The program organization section of the post-test questionnaire was measured
from 1 (Strongly disagree) to 5 (Strongly agree) as factors that attracted participants to
the program). Overall participants strongly agreed that the setting, length of program
were appropriate and the facilitator and or key speaker was credible. The following
graph demonstrates the overall distribution of scores relating to the participants'
satisfaction with the program organization on all the aspects measured in both the pre-
test and the post-test.
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Figure 4.15: Distribution of Program Organization Scores
Once again, a closer look at the program organization mean score results in the post-test
shows that while all factors measured were highly important to the program, the speaker
was the most important factor.
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Figure 4.16: Program Organization Mean Scores
In the post-test other factors were also added to program organization that could
only be measured after the program took place. These related to the participants
experience during the program. These factors were: quality of teaching materials such as
handouts and slides, overall program balance/credibility, clarity of information,
speaker's knowledge and time for questions and interactivity. These factors were rated
on the same scale as the program organization from 1 (Strongly disagree) to 5 (Strongly
agree). The following graph illustrates the mean score results for post program
organization.
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Figure 4.17: Awi-Program Organization Mean Scores
e) Barriers to Application (Additional Post-Test Questions)
An additional section was added to the post-test questionnaire in order to
identify any potential barriers to the application of knowledge and skills from the
educational program. The following clinical practice barriers were considered on a scale
from 1 (No barrier) to 5 (Major barrier), lack of experts to consult with, lack of
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accessibility to follow up materials, lack ofnecessary equipment, lack of time, and lack
of financial resources. Participants were also prompted to identify any other barriers that
were not listed in this section. However, participants did not respond to this question
and no further barriers were identified. The graph below summarizes the mean scores
for each suggested clinical barrier.
Barriers to Application (Additional Post Test Questions)
B Mean'
Lack of Lack of Lack of Lack of time to Lack of
experts to accessibility to necessary implement financial
consult with in follow up equipment to new practices resources to
applying new materials to apply new implement
know ledge reinforce my know ledge new practices
w ith my changing ny gained
patients practice
Figure 4.18: Barriers to Application (Additional Post Test Questions)
The post-test results for Barriers to Application received an overall low rating.
The mean scores ranged from 2.25 to 2.67 on a scale from 1 (No Barrier) to 5 (Major
Barrier). The highest rated barrier was "Lack of follow up tools to reinforce changing
my practice" with a mean score of 2.67, followed by "Lack of time to implement new
practices" with a score of 2.36, and "Lack of experts to consult with in applying new
knowledge with my patients" at 2.33. The lowest rated barriers were "Lack of necessary
equipment to apply new knowledge gained" with a mean score of 2.25, and "Lack of
financial resources to implement new practices" with a score of 2.28. These scores
indicate that while there do not seem to be any major barriers to applying new
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knowledge as identified in the questionnaire, a lack of follow up tools, time and experts
to consult with are the top barriers concerning participants in the educational activity.
Since participants did not offer any other barriers in this section, no additional
information was provided in the post-test.
Overall, the results from the post-test questionnaire showed that participants
rated the program's learning objectives and topic as very important and very relevant to
their practices. Some learning objectives in the post-test were more important than
others. Participants also intended to apply what they learned in the program and were
confident that they would do so in their practices although they were more or less sure
how they would implement changes in the treatment of their patients. All factors
measured in the program organization proved important in attracting participants to the
event. The facilitator and/or key speaker however were rated as the most important
feature of all. Additionally, in the post-test extra post program organization factors were
considered. These related to the quality of teaching materials such as handouts and
slides, overall program balance/credibility, clarity of information presented, speaker's
knowledge and time for questions and interactivity. All factors scored very high by
participants. Once again the factors relating to the facilitator and speaker's skills rating
the highest. The proposed barriers to practice application in the post-test did not yield
high mean scores. No additional barriers were offered by participants.
4.1.4 Comparison ofthe Pre-Test and Post-Test Results
To compare the results of the post-test to those of the pre-test the Sign test was
selected. The data are ratings (ordinal data) and therefore a non-parametric test was
appropriate. The Wilcox Sign test is a non-parametric test for assessing whether two
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dependent samples of observations come from the same distribution. The Sign test is
considered when samples are small and the distributional assumptions necessary for the t-
test come into question. The null hypothesis concerns the identity of the two population
distributions and if the two population distributions are of even moderately similar shape
and variability (StatSoft, 2009).
The null hypothesis for each question that there was no difference between the pre- and
post-test results; while the alternative hypothesis was that there was a significant
difference.
The results comparing the pre and post-test questions using the Wilcox Sign test showed
the following:
a) Importance of Learning Objectives
The null hypothesis was accepted for all questions in this section as there was no
statistical difference between the pre- and the post-test scores for all four learning
objectives (p <= 0.81, ? <= 0.88, ? <= 0.87, ? <= 0.89 respectively). The table below
highlights the Importance of Learning Objectives pre and post-test scores using the
Wilcox Sign test.
Table 4. 5: Importance ofLearning Objectives Wilcox Sign Test Results
QUESTION 1: Importance of Learning Objective I
n+ 10,n-8,p<=0.81
QUESTION 2: Importance of Learning Objective II
n+ 22, n- 24, ? < = 0.88
QUESTION 3: Importance of Learning Objective III
n+20, n- 18, p< = 0.87
QUESTION 4: Importance of Learning Objective IV
n+ 27, n- 25, ? < = 0.89
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b) Relevance to Practice
The null hypothesis for question 5 and 6 in this section was accepted as there
was no statistically significant difference between the pre- and post test scores for this
question of the Relevance to Practice section (p <= 0.84 and ? <= 0.69 respectively).
However, the null hypothesis for questions 7 and 8 was rejected, as there were
statistically significant differences between the pre- and post test scores for these
questions of the Relevance to Practice section (p <= 0.02* and ? <= 0.02*
respectively). The table below highlights the Importance of Relevance to Practice pre
and post-test scores using the Wilcox Sign test.
Table 4.6: Relevance to Practice Wilcox Sign Test Results
QUESTION 5: The topic of this program is highly relevant to my clinical practice
n+ 12, n- 14, ? <= 0.84
QUESTION 6: The topic of this program is unrelated to my practice
n+27,n-31,p<=0.69
QUESTION 7: The knowledge I gained in attending this program will improve my
clinical practice
n+ 34, n- 58, ? <= 0.02*
QUESTION 8: I have patients who will benefit from my increased knowledge about
this topic
n+72,n- 104, ? <= 0.02*
c) Perceived Impact on Practice
The null hypothesis for question 9 in this section was accepted as there was no
statistically significant difference between the pre- and post test scores for this question
of the Perceived Impact on Practice section (p <= 0.62). However, the null hypothesis
for questions 10 and 1 1 was rejected, as there were statistically significant differences
between the pre- and post test scores for these questions of the Perceived Impact on
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Practice section (? <= 0.04*, ? <= 0.008* respectively). The table below highlights the
Perceived Impact on Practice pre and post-test scores using the Wilcox Sign test.
Table 4. 7: Perceived Impact on Practice Wilcox Sign Test Results
QUESTION 9: To what extent do you think you will apply what you will learn in this
session to the treatment of your patients in your clinical practice
n+16,n-20, p<=0.61
QUESTION 10: Have you considered how you will implement changes in your
treatment of patients following this program
n+ 45, n- 27, ? <= 0.04*
QUESTION 11: How confident are you that you will apply what you will learn in this
program to the treatment of your patients
n+ 80, n- 49, ? <= 0.008* .
d) Program Organization
The null hypothesis for all questions in this section was accepted as there was no
statistically significant difference between the pre- and post test scores (p <= 0.47, ? <=
0.08, ?+ 7, ?- 5, ? <= 0.77 respectively). The table below highlights the Importance of
Program Organization pre and post-test scores using the Wilcox Sign test.
Table 4.8: Program Organization Wilcox Sign Test Results
QUESTION 18: Setting would be appropriate for learning
n+27,n-21,p<=0.47
QUESTION 19: Length of program would be appropriate
n+31,n- 18, ? <= 0.085
QUESTION 20: Facilitator/key speaker(s) is credible
n+ 7, n- 5, ? <= 0.77
Overall, the results comparing the pre and post-tests for this program showed
some statistically significant differences concerning the relevance of the topic to
participants' practice and the confidence of the participants to apply what they learned
from the educational program.
4.1.5 The one Month Follow-up Interview Descriptive Statistics
The follow up interview guide was designed as a structured questionnaire for
sponsor representatives to follow up with participants one month post CHE event to
collect feedback on the event and assess the impact of the CHE program as it relates to
the participants' reaction to the program, perception of knowledge gain, views on
relevance to practice, intended and actual practice change, perception of impact on
patient outcomes, perceived value of the program, as well as any change in sponsor
representative interaction with the participant. The follow up guide consisted of sixteen
closed ended questions using the likert 5-point scale to rate individual responses from 1
(Not at all) to 5 (Very much) (see appendix 3). It also included two additional open
ended questions relating to any further assistance the sponsor representative could
provide as an outcome of the program and understanding the specific barriers that
prevent the health care professional from implementing what was learned. The follow-
up interview was conducted on a completely voluntary basis by participants. A total of
n=34 out ofn= 173 participants agreed to complete the one month follow-up interview.
4.1.6 Resultsfrom the One Month Follow-up Interview
The results of the one month follow up interview demonstrate that participants
thought positively about the educational program and found the program both relevant
and useful to their practice. The program was successful in making participants think
about their current practice and had an impact on health participants' practices.
Although the program was not reported to have any impact on patient outcomes by
participants, the educational activity was reported by participants to be highly valued.
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Sponsor representatives reported some positive changes in their relationship with the
participants. The details regarding the follow up interview results are given below,
a) Reaction to the program
The interview results one month post program demonstrates that overall
participants thought positively about the educational program. Participants rated the
question What didyou think about the program? a mean score of 3.70 on a scale from 1
to 5. Feedback obtained from some representatives conducting the interview was that
overall participants felt it was a "good" and "thorough" program. The results from the
interviews also show that participants felt the program was credible and unbiased. The
mean score for this question was 3.88 on a scale from 1 to 5. Finally, the follow up
interviews demonstrated that participants for the most part did not yet have a chance to
speak to other health care professionals (HCPs) who attended the program about any of
the content. The mean score for this question was 2.06 on a scale from 1 to 5. Feedback
which was written on some of the interview guides suggested that for some of the
participants it was too early, as comments such as "not yet" and that "it has not come up
yet" were written down beside the question. The following table highlights the mean,
standard deviation, median and mode scores for the "Reaction to the program" section.
Table 4.9: Follow-up Interview: Reaction to Program Scores
Follow up Intetview: Reaction to Program
\ What did you think about the program?
Was the program content credible and unbiased?








b) Views on Relevance to Practice & Perception of Knowledge Gain
The results for Views on Relevance and Perception of Knowledge Gain from the
post event interviews show that overall participants found the program relevant and
useful. Participants rated the question Do you see patients who can benefitfrom the
64
program? a mean score of 3.65 on a scale from 1 to 5, and Were the knowledge and
skills presented in this program useful? a mean score of 3.4 on a scale from 1 to 5.
However, the perception from the representative one month after the event was that
participants did not gain as much knowledge and skills as the participants suggested.
Representatives conducting the interviews rated the health care professionals'
knowledge gain a mean score of 2.5 on a scale from 1 to 5. The following table
highlights the mean, standard deviation, median and mode scores for the "Views on
Relevance to Practice & Perception of Knowledge Gain" section.
Table 4.10:
Follow-up Interview Relevance to Practice/Perception ofKnowledge Gain Scores
FofeuffiteorieW; Relevance to practice/Perception of knowledge Gain
Do you see patients who can benefit from the program?
Were the knowledge and skills presented in this program useful?










The difference between the participants' responses and the representatives'
responses can be explained by the heterogeneous sample. The sample consisted of case
workers, nurses, specialists, support group/social workers and family physicians. In
looking closer at the data relating to this question both the mode and the median was a
score of 3 on a scale of 1 to 5. The minimum response was 0 (although the lowest rating
was supposed to be 1 , representatives wrote 0 or N/A beside questions) and the
maximum response was 4. This indicates that although most representatives felt that
participants did gain knowledge there was a great variance for a few respondents from
not gaining any new knowledge because of their ability to implement key learnings in
the treatment of their patients. The lower ratings for some participants skewed the
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distribution of the data. The following table illustrates the distribution of scores for the
CHE champion's perception of knowledge gain question.




Figure 4.19: CHE Champion Perception of Knowledge Gain Score Frequency
Furthermore, the additional qualitative feedback from respondents in this area
was that depending on their role some knowledge was more useful for some than others.
Frequently the comment "Case worker" "Cannot apply treatment information" or "Not
an MD" was written on questionnaires. Sometimes these comments were written in bold
and rather large letters at the top of the interview questionnaire by the representatives as
a point that came out of discussions in interviews. Therefore depending on who the
representatives were following up with, some participants displayed a greater
appreciation for the application of gained knowledge and skills than others and this in
turn influenced the representatives' perceptions,
c) Intended and Actual Practice Change
The results for Intended and Actual Practice Change from the post event
interviews show that the program was successful in making participants think about
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their current practice. This question was rated a mean score of 4.29 on a scale from 1 to
5. The program also helped to change participants' practices. When participants were
asked if they are doing anything differently in their practice as a result of the program
participants rated this a mean score of 3.94 on a scale of 1 to 5. This was further
confirmed by the representatives' perception of practice change which was rated a mean
score of 3.62 on a scale of 1 to 5 and in line with the respondents' answers. The
following table highlights the mean, standard deviation, median and mode scores for the
"Intended and Actual Practice Change" section.
Table 4.11: Follow-up Interview: Intended Practice Change Scores
Follow up Itilewevr. Intended Practice Change
Did anything in the program make you think about your current practice?
Are you doing an/thing differently as a result oí viïiat you ¡earned in this program?










Qualitative data was also collected by the representatives to identify what
exactly health care professionals were doing differently as a result of the program.
Participants identified three major themes. Participants were a) sending away for tests
that they did not perform in the past b) conducting tests at an earlier stage than
previously or c) considering using more than one active agent for treating patients. The
following is a sample of the responses that were obtained: "sending in tropism tests",
"earlier tropism test", "requesting profile tests", "R5 tropic or not", "considering
tropism", "obtaining tropism data" "including tropism in the treatment decision" and
"seeing a need for 3 active drugs".
Furthermore, representatives also asked participants to list any barriers to
implementing changes in their practices. The following themes were identified a) access
to tests were a barrier b) labs were a barrier c) requirements for tests were a barrier. The
67
following is a sample of responses obtained: "1000 VL requirement", "need for 1000
viral load", "blood test is a barrier" ,"blood test difficult", "blood test slows it down",
"labs collecting blood" "labs slow it down" "tropism" , "tropism test" and "labs",
d) Perception of Impact on Patient Outcomes
The results for Perception of Impact on Patient Outcomes from the post event
interviews show that the program did not have any significant perceived impact on
patient outcomes. Participants rated this question a mean score of 1 .53 on a scale from 1
to 5. Feedback to explain this answer was communicated very clearly as comments in
the interview questionnaires by the representatives. The participants cited for the most
part that it was "too early" in the process to have any impact whatsoever on patient
outcomes. The following table highlights the mean, standard deviation, median and
mean scores for the "Perception of Impact on Patient Outcomes" section.
Table 4.12: Follow-up Interview: Perception ofImpact on Patient Outcomes Scores
Foilow yp lnteÉw; Perception of Impact « Palien! Qufcoros




e) Perceived Value of the Program
The results for Perceived Program Value from the post event interviews show
that the program was highly valued by participants as it was rated a mean score of 4.02
on a scale of 1 to 5. The following table highlights the mean, standard deviation, median
and mode scores for the "Perceived Program Value" section.
Table 4.13: Follow-up Interview: Perceived Program Value Mean Score
Followilp Interview: Perceived P^ram^^/v >






f) Changes in Sponsor Representative Interaction with the Participant
The results for Changes in Sponsor Representative Interaction with the
Participant from the post event interviews show that the program had some impact on
the representatives' perception of their relationship with the participant. In this section 5
out of 6 questions were aimed at the representative's impressions. Representatives rated
the amount of time, potential for follow up and change in tenor of discussion among the
most positive outcomes as a result of organizing the educational program. Increased
Time was rated a mean score of 4.5, Follow up in Providing Care to Patients was rated a
mean score of 3.67 and Change in Tenor of Discussion with Participant was rated a
mean score of 3.58 all on a scale of 1 to 5. In terms of increased time for representatives
the respondents commented that they viewed prioritization over representatives from
other companies and frequency of visits as being the most changed variable post
program.
The program did not seem to affect the length of visits, the number of requests
for information or samples nor the scope of the discussion. However the representatives
commented that it was "too early" to tell as it had only been approximately one month
since the program and for many representatives this was the first time they had visited
with the participant since that time.
The only question in this section directed towards the participants was
concerning the potential for representatives to follow up in providing care to patients.
This question was rated positively with a mean score of 3.68 on a scale from 1 to 5. The
feedback from participants was there was a variety of follow ups that could be provided.
The following are a sample of comments that were cited: "looking for updates in
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research", "patient pamphlets", "Resource Program", "keep me updated on new
information", "next speaker programs" and "tools". The following table highlights the
mean, standard deviation, median and mode scores for the "Changes in Sponsor
Representative Interaction with the Participant" section.
Table 4.14:
Follow-up Interview: Interaction between CHE Champion and Participant Scores
Fojlpff fcíerów: Interaction Sefwéen CHE Criampiortand Participant
i increased time for CHE Champion
¡Len^hoivia
! Follow up in µ?????) care to yew patents? Informáion? Research! Guidelines? Jools?
lChange in scope of discussion between WCP and CHE Champion
Increase in requests for iníormáon, samples, interaction












Overall, the interview results one month post program demonstrates that
participants thought positively about the educational program and found the program
both relevant and useful to their practice. The program was successful in making
participants think about their current practice and showed that the program also had an
impact on participants' practices. Additionally, the educational activity was highly
valued by the participants. However, one month was consistently cited as being "too
early" for the program to have any impact on patient outcomes. Finally, representatives
reported that organizing the program positively affected the amount of time, follow up
opportunity and tenor .of discussion with participants. However, the program did not
impact the length of a visit, scope of discussion or requests for general information and
product samples.
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4.2 Results of the Scorecard
The results of the return on educational value model scorecard for the CHE
program in this research are calculated below.
Table 4.15: Return on Educational Value Model Scorecard
SCORECARD
Pre- Post-event Questionnaire - '
Importance of Learning Objectives
¡1 . Very Important - S. Not Important
Average Average Aaeragè
^iPre-Event Post-Event Difference;
I 4.20| 4.501 O.OSl
Relevance to Practice : I 3.791 3.54| -0 28|
Jl .ärongjy Disagree -j^Strongjy Agree
; Perceived Impact on Practice
jl. Very Miich-5- NoíataO
4.00I 3.30I -0.0TI
Barriers to Application
;1 . No Barrier - S. Major Barrier
2.39 1
Program Organization
A . Strongly Disagree - S. Strongly Agree
1.461 0.10
Overall Average 4.1B 4.15 -0.03
Post-One Month Questionnaire
1. Reaction to Program
2. Perception of Knowledge Gain. Relevanc
3. Practice Change - Intended and Actual
4. Perception of Impact on Patient Outcon*
5. CHE Champion Interaction with Client











1 4 (objectives change) + 1 4 (relevance change) + 1 4 (impact change) + 7 (organization change) + 7 (FAJ
The components of the ROEV model scorecard are a) the average difference in
pre and post-test scores of the learning objectives section combined, b) the average
difference in pre and post-test scores of the relevance to practice section combined, c)
the average difference in pre and post-test scores of the perceived impact on practice
section combined, d) the average difference in pre and post-test scores of the program
organization section combined, e) the overall average of the post program follow-up
interview questions. Each average section score of the pre and post-test and individual
interview sections score are then weighted according to the organizations' priorities and
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definition of "value" for educational programs. This approach was used in order to
further link together the provider's organizational objectives as well as the assessment
of the overall program in addition to the specific activity assessment (Gilman, 2002). In
this case the change in learning objectives, relevance to practice, impact on practice and
the CHE champion's interaction with participants average score were weighted twice as
much as all the other domains since these areas were viewed as most important to the
organization and CHE division. This was done by calculating the following equation:
(14*learning objectives average difference)+(14*relevance to practice change average
difference)+(14*impact on practice change average difference)+(7*program
organization average difference)+(7*reaction to practice average score)+(7*perception
of knowledge gain average score)+(7*practice change intended and actual average
score)+(7*patient outcomes average score)+(16*CHE champion interaction average
score)+(7*perceived program value average score))/100. This score (1.63) was then
divided by 5 to provide an overall total percentage score signifying the program's return
on educational value. In this case the program demonstrated a return of 32.66%.
It is important to note that for this model of calculating return on value for
educational programs any score greater than 1 or greater than 20% is a positive gain
based on the organization's definition of "value" and any score less than 1 or less than
20%) is considered a negative decline or a loss in "value". This is because the 1 or 20%)
represents the minimal score on all instruments using the likert 5-point scale and
therefore this represents the break-even point. The percentage score does not a represent
return on investment (ROI) in monetary value but rather an indicator of overall "value"
as defined by the educational provider.
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In this case the program received a total gain of 32.66%. Practically speaking this
translates into an incremental gain of 12.66% in 'value' or 'benefit' to the organization.
The scorecard demonstrates that gains in value resulted from the following variables:
the importance of the program's learning objectives (0.06) from the pre-post tests, the
participants' reaction to the program (3.21), the participants' perceived knowledge gain
(3.18), the participants' actual and intended practice change (3.95), the CHE champion's
interaction with client (3.40), as well as the participants' perceived value of the program
(4.05) from the one month post program follow up interviews. The losses in value
resulted from the following areas according to the ROEV model scorecard: the
relevance to practice (-0.28), the perceived impact on practice (-0.01) and the program
organization (0.10) from the pre-post tests, as well as the perception of impact on patient
outcomes (1 .53) from the one month post program follow up interviews. Since the
following areas were 'double weighted' the results from the following areas contributed
twice as much to the final score of the program: importance of learning objectives,
relevance to practice, and perceived impact on practice from the pre-post tests and the





5.1. Discussion of Findings
This research thesis includes a review and critical synthesis of literature relevant
to return-on-investment (ROI) and continuing health education (CHE). Through an
empirical investigation into calculating return on educational value in the
pharmaceutical industry, this research contributes to the overall knowledge of return-on-
education modeling in a new and under-studied market. In addition, this research
presents insight into the potential of a new model for assessing the value of investment
into educational initiatives worthy of consideration by academics, the medical
profession, industry professionals, and other key stakeholders.
This research focused on a variety of health care professionals working in the
field of HIV. Included were Specialists, Family Physicians, Nurses, Pharmacists, Support
Group & Social Workers as well as Case workers. Convenience sampling was used for
all health care professionals participating in a continuing health education program
sponsored by a Canadian subsidiary of an international pharmaceutical company. In total
1 73 Health Care Professionals participated in this research project from across Canada.
The objective of this study was to develop and assess a model to determine the
impact of a particular CHE program. A model was developed which identified the major
domains of valued outcomes for the subsidiary of an international pharmaceutical
company in order to measure the impact of CHE programs on specific value targets.
This approach was used in order to further link together the provider's organizational
objectives as well as the assessment of the overall program in addition to the specific
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activity assessment (Gilman, 2002). The CHE program serving as an educational
intervention was focused on the area of HIV. The learning objectives were as follows:
At the end of the program, participants will be able to:
- Understand the course of disease progression with
CCR5 vs. CXCR4 tropic viruses
- Review the latest evidence on new therapies for
treatment-experienced patients in HIV
- Describe the place of CCR5 antagonists in HIV management
- Apply clinical trial results to the management of
treatment-experienced patients in their practice
The program was case-based and centered on finding ways through new novel therapies,
to achieve maximal response in patients having previously received antiretroviral
therapy for HIV. The program proposed participants test for different categories of
resistance/cro'ss-resistance and identify specific mutations in order to choose appropriate
treatments and discussed the place for the various treatments according to guidelines
and specific objectives of treatment.
Pre and Post tests as well as a one month follow up interview were implemented
to measure the outcomes of the program and generate a scorecard to measure the overall
"value" of the program to the organization. The pre and post-test questionnaires and
follow up interview guide were all based on the Dixon four levels of evaluation. One
month later, structured follow up interviews were implemented in order to provide further
qualitative feedback on the program and obtain further insight into the results of the pre-
post questionnaires.
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The results comparing the pre and post-tests for this program showed some
statistically significant differences on the participants' perceptions concerning the
relevance of the topic to their practice and the confidence of the participants to apply
what they learned from the educational program. The one month follow-up interviews
also helped to confirm, explain and provide suggestions for future areas to explore. The
interviews confirmed that participants viewed the educational program positively and
found it relevant, valuable and useful to their practice. They confirmed initial results from
the pre and post-tests by suggesting that the program did have some effect on
participants' practices despite significant barriers to implementing clinical practice
changes as well as a very heterogeneous sample participating in the educational program
with limited ability to effect changes in practice. The interviews also suggested areas of
positive change in the relationship between the participants and the sponsor
representatives.
Verbal feedback during the educational activities which was not captured as part
of the questionnaires or interview questions further emphasized the barriers to practice,
specifically relating to the tests proposed in this educational program. These were the
tests required to make use of the new novel therapies also identified and explained in the
module. This feedback was reported in an informal way to the Therapeutic CHE
manager directly involved with the research project. Some of the steps involved in such
tests were as follows:
-3.0 mL of plasma must be sent for optimal performance of the assay, for best
results, viral loads should be confirmed within the two weeks prior to
submission for testing,
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-the assay is intended for use only for patients with viral loads >1,000 copies/mL
-Draw whole blood into either two 5.0 mL PPT (pearl top)
or two tubes containing EDTA anticoagulant (lavender top)
-Immediately centrifuge blood (within 2 hours of collection)
at 1,000-1,200 ? g at room temperature (18-25oC)
for 10-15 minutes
-For EDTA samples: after centrifugation, immediately remove plasma from cells
and transfer to a screw-cap top tube
-Immediately after centrifugation, freeze plasma sample
at or below -20oC in a standard laboratory freezer.
Sample should be frozen when courier arrives to pick it up.
-DO NOT THAW SAMPLE AFTER FREEZING!
Additionally, the verbal feedback from participants during CHE events was that the
steps involved in administering the tropism tests were "difficult" to implement. The
tropism test was required to verify cell receptors and to determine if a patient was a
good candidate for a specific therapy. The test results needed to be sent in to a site in the
United States in order to obtain results at time of launch of this program. This eventually
changed to regional sites within Canada; however this occurred sometime after the
program was rolled out. Additionally, the associated testing costs were high. Therefore
the required tests were initially viewed as a roadblock upon initial roll out of the
program. This could explain some of the decreased score results for the post test
questions relating to impact on practice and perhaps explain why participants were more
or less sure how they would implement potential changes in their treatment of patients
following the program.
The heterogeneous sample participating in this program seemed to also play a
role in the results of the study. The faculty responsible for the development and design
of the program consisted of a group of Infectious Disease Specialists, Internal Medicine
Specialists, Pharmacologists and one General Practitioner. However, the audience
participating in programs consisted of Inter-professional or Inter-disciplinary groups
including Specialists, General Practitioners as well as other Allied Health Professionals
such as Nurses, Nurse Practitioners, Pharmacists, Social Workers and Case Workers.
Since the program was case-based with a main focus on a) tropic viruses, b) the latest
evidence on new therapies and c) the application of clinical trial results to patients in
their practice, it would make sense that the program would be of interest to everyone
from an educational standpoint. However, the program without a multi-disciplinary
design approach built in to represent everyone's role, seemed to have limited impact
with the Allied Health participants in terms their initial reaction to the program and in
terms of any potential impact on their practices.
The time allotted between the educational event and the follow up interview
proved to also play an important role in the study. On a consistent basis participants
reported one month post event that it was "too early" to put into practice the learnings
from the educational intervention with their patients. Also, one month post event very
few participants had the opportunity to engage with other participants to exchange on
the content or any key insights from the program. This would seem to indicate that the
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time required for an educational activity to impact practice is longer than originally
estimated.
Perhaps one of the most interesting results from this research came out of the
one month follow up interviews. This was concerning the perception of sponsor
representatives themselves that the program helped to produce a positive change in the
relationship between the participants and the sponsor representative. Positive changes
included "Increased Time" "Follow up in Providing Care to Patients" and "Change in
Tenor of Discussion with Participant". In terms of increased time for representatives the
respondents commented that they viewed prioritization over representatives from other
companies and frequency of visits as being the most changed variable post program.
These results are interesting because they are based on the internal perceptions of the
representatives organizing the CHE activities and demonstrate the variety of ways that
the educational program supports interactions occurring between participants and
representatives long after the program is completed.
The scorecard that was generated using the proposed ROEV model demonstrated
that the program produced a total gain in value of 32.66% to the organization. This
amounts to an incremental gain of 12.66% from the break even threshold of 20%. As
Davis argued, to effectively demonstrate the outcomes of CHE efforts evaluation should
focus on identifying, measuring, and describing the value provided by a program or
activity (2003). The scorecard provides a broad high level view of where CHE is
contributing to particular value targets, assesses where CHE initiatives are succeeding or
failing to meet expectations, and helps to monitor and guide future CHE initiatives to
maximize return on educational value (ROEV). It is important to note that according to
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this model that the participants' high rankings on pre-tests impact the overall score. For
example, if participants rank the program high on the pre-test prior to the program and
then again rank the program high again on the post-test, the difference between both
ranks will be minimal. This needs to be considered in any future utilization of the
scorecard as it impacts the overall score and can be misleading regarding potential
weaknesses associated with the overall educational program.
Unlike the measurement of return on investment (ROI) which is a financial
exercise, the final score of the ROEV model is intended as an indicator of the
educational value of a given program based on specific corporate targets. In this case,
according to the ROEV scorecard the CHE program is succeeding most in addressing
knowledge gain, providing value and intended practice changes for learners, as well as
helping CHE champions improve interactions with the participants attending the
educational activities. However, the CHE program is failing most to meet expectations
on demonstrating any perceived impact on clinical practice and patient outcomes
(according to the scorecard's calculations). These findings from the Scorecard indicate
that CHE efforts are performing well on conducting educational needs assessments and
identifying the most relevant course objectives for participants. CHE efforts are also
helping to strengthen and improve interactions between representatives and customers.
However, more CHE effort should be focused in demonstrating a higher degree of
perceived impact on clinical practices as well as patient outcomes.
These results are both confirmed and challenged in both the pre-and post test
results using the Wilcox Sign test and the one month post program interviews. Results
from the Wilcox Sign test demonstrated little statistically significant changes in both
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groups; this suggests a fair amount of overlap between the two groups. The only
exceptions were some differences between both groups in terms of Relevance to
Practice as well as Perceived Impact on Practice in the one on one interviews. This can
be explained by the heterogeneous sample and important barriers to practice change.
The follow-up interviews demonstrated the relevance of the program to participants as
well as practice changes occurring as a result of the program. It further demonstrated a
positive impact on the relationship between the participant and the representative and
suggested more time would be required to see any improvements in patient outcomes as
a result of the educational intervention.
Although the scorecard provides confirmable and reproducible results, the
scorecard by itself does not fully explain results. The scorecard, by using only mean
scores from pre-and post tests, does not account for the ordinal rank scores and
distributional assumptions. Furthermore, the ROEV scorecard also does not address the
context in which the program was implemented, the beliefs and perceptions of the
participants and the representatives implicated in the programs, the explanations of
existing barriers to application, the examples of actual clinical practice change, the
potential follow up actions, the tools and resources that can help encourage practice
changes, the ways in which CHE champions are benefiting from the program in their
interactions with clients, nor the existing differences among participants attending the
educational event. By using only mean scores, the ROEV Scorecard assumes population
normality and homogeneity of variance and does not account for any qualitative data. It
does not address how, why and when health care professionals change behavior nor
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does it help to pinpoint what more can be done to further facilitate changes in practice
and impact in patient outcomes.
5.2. Overall significance of the study
This research thesis builds on the existing body of knowledge on the
effectiveness of CHE and further extending them to the Canadian context. The findings
complement existing literature on return-on-investment models and help to provide a
good starting point for future research designed to measure the effectiveness of CHE
activities. This research proposes a Return on Educational Value Model for CHE
offerings that was piloted within a Canadian subsidiary of an International
pharmaceutical company and provides reliable and valid information about the impact
of a CHE program using Dixon multilevel evaluation models. Finally, factors that
contribute to an effective CHE activity are identified.
This research is significant for a number of reasons. Beyond helping the CHE
Division of the Canadian subsidiary of an International pharmaceutical company to
better assess the value of educational investments and to justify its resources, it also
helped the organization improve its understanding ofmeasuring "value added"
investments. It also adds to the research within the CHE field which currently describes
a variety of promising evaluation models but requires considerable testing and
refinement with more research in order to provide more sophisticated information about
the impact of CHE for a variety of stakeholders involved in this form of education.
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5.3. Relationship of results to existing studies
This research suggests that participation in educational programs combined with
sufficient time to allow participants to begin clinical practice changes with appropriate
follow-ups to the program, is likely to have a high degree of impact on health care
professionals practices. This is consistent with recent literature which has shown that
changing health care outcomes requires multiple educational interventions including a
formal CHE activity followed up by small group interventions as well as a concerted
effort in providing effective patient education (Davis, 2006).
The program's weakest domain according to the ROEV model scorecard was
its perceived impact on patient outcomes. In the comparison between pre and post-test
results using the Sign test, the results showed some statistically significant differences
on the participants' perceptions concerning their confidence to apply what they learned
from the educational program. The one month post program follow-up interviews
expanded on this as the qualitative data and suggested that participants felt it was "too
early" to answer the question of whether or not they have seen any improvement in the
impact of their management ofpatients as a result of attending the program. Although
participants indicated they were in effect starting to implement some practice changes
related to patient testing, according to the follow-up interviews the changes were
difficult to carry out due to barriers in application. Barriers were primarily related to the
steps involved in testing patients and to the heterogeneity of participants attending the
program in their ability to carry out changes due to limitations in their role. Participants
offered ways for representatives to help facilitate changes in their practices by citing
resource programs, tools, patient pamphlets, updates in research, and further educational
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programs as highly valued post program offerings. This underlines the importance
following up on key knowledge and skills to facilitate changes in practice over time to
ultimately effect patient outcomes.
5.4. Limitations
There are several limitations to this study that need to be acknowledged. The
first limitation is concerning the study design. The study design for this research project
was a pre-experimental design. A pretest, post-test, and structured one month follow up
interview were implemented without any control group. Although the one month follow
up interview served to reinforce the internal validity of the research, the major weakness
of any design without a control group it is difficult to know if the effects of the
educational intervention may have actually been responsible for the results. Single
group threats for this study included history and testing threats. The results of this study
were also based on participants' self-assessment and perceptions therefore the research
was not based on actual observations. This represents another weakness of this research.
The second limitation of this study surrounds the instruments used in this research.
Although the questionnaires and follow up interview guide were developed according to
appropriate principles in instrument/questionnaire design and demonstrated reliable
results throughout the study, they were not validated instruments. Therefore the validity
of the results may be questioned. The third limitation is concerning the sample.
Convenience sampling was used for this study. The resulting sample consisted of a
heterogeneous group of health care professionals working in the HIV field including
specialists, nurses, family physicians, pharmacists, case workers, support group and
social workers. As participant information was optional for participants to complete no
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demographic or any specific participant characteristic information was obtained for the
sample. Therefore the results cannot be considered representative of a particular group.
Finally, a fourth limitation to this research is a potential bias associated with company
representatives sponsoring the educational program collecting pre-post tests for this
research and implementing the one month post program follow up interviews
themselves. Additionally, the participants attended the educational program based on
their own existing interests in the topic and therapeutic area and therefore this may be
cause for potential bias as well. The findings of this research are therefore subject to
under-reporting bias with interventions.
5.5 Implications for future research
The findings of this study demonstrate the need for further research in six key
areas relating to measuring the return of CHE interventions within the pharmaceutical
industry. Firstly, industry sponsored CHE activities are typically implemented and
evaluated as a one time event. For certain types of industry sponsored CHE events this
is justified, such as a yearly congress symposium. However, for other types of CHE
programs implemented in an on-going basis, future research should explore the results
from multiple CHE events in multiple different formats implemented as a concerted
effort to impact changes in patient outcomes. Studying CHE activities as applied in a
variety of formats with a similar group of health care professionals over time would help
to better understand the impact of sustained efforts to impact participants' clinical
practice and patient outcomes. It would also provide valuable insight into the amount of
time required for changes to begin occurring in practice as well as the specific type of
follow ups required to adequately reinforce key learning objectives.
85
Secondly, as the CHE field evolves towards an emphasis on practice changes
and patient outcomes as target measures of CHE, the one shot pre-post test evaluation
design needs to be reconsidered. The field of CHE has become dependant on the one
shot pre-post test design to evaluate all CHE activities largely because it has been an
effective measure of knowledge translation to date and is the most simple and
convenient assessment design available. However, the one shot pre-post test design
represents a participant's self assessment of his or her own attributes or characteristics
based on participation at one single educational activity, not on an on-going basis. This
method of evaluating changes in practice and outcomes on patients is sub-optimal for
such variables which according to the literature occur over time and generally as a result
of more than one intervention. Therefore future research should focus on identifying,
developing and evaluating a variety of validated behavior and/or practice change
instruments and implementing them within CHE program assessment to find more
effective ways of measuring these types of outcomes.
Thirdly, as the CHE field focuses its efforts on measuring outcomes related to its
impact on practices and patients, investigators should more carefully consider what
types ofpractice changes and patient outcomes are being targeted. Future research
should seek to identify the types of practice changes which are most effectively
achieved through CHE activities. Further insight into this area would allow CHE
providers to better understand where and when and with whom CHE can play a role to
effectively impact changes in practice and similarly when changes may be too great
and/or complex, involve too many steps to effectively be applied, or simply be
unrealistic.
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Fourthly, more studies are required on barriers to change and their impact on the
effectiveness of CHE programs. A better understanding of the impact ofbarriers to
change on the effectiveness of CHE would allow educational providers to plan more
effectively for barriers within the development of programs, determine the exact role
and nature of barriers for specific types of programs, and better evaluate the risks versus
benefits of developing programs associated with specific barriers. This type of research
would be invaluable to not only improve the effectiveness of the educational
intervention but also to better understand where when and with whom CHE can play a
role to effectively impact changes in practice and patient outcomes as well as when
barriers to change may be too great for any changes to be applied.
Fifthly, the area of inter-disciplinary and inter-professional education needs to
be better understood. Over the past few years the field of CHE has witnessed the growth
of interdisciplinary and inter-professional education. As Health Care Professionals in
Canada increasingly work together in teams the educational interventions that are
offered to them and implemented within CHE need to reflect this reality in both their
development/design and implementation in order for the educational programs to be
truly effective. Assessment instrument and tools need to also take into consideration the
various "lenses" that educational programs are being looked through with heterogeneous
groups of participants and incorporate this into their design.
Sixthly, more studies such as this are needed to further develop and refine
models of calculating gains or losses from educational programs using the most
appropriate methods. The model developed for this study can be thought of as a starting
place in an aim to demonstrate the value of CHE within an organization. Although it
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demonstrated significant findings, the increasing need for continuing health education
coupled with the significant investment required warrants further investigation into a
model to measure the overall value of these activities for all stakeholders involved in
CHE.
5.6 Conclusion
This research thesis includes a review and critical synthesis of literature relevant
to return-on-investment (ROI) and continuing health education (CHE). Through an
empirical investigation into calculating return on educational value in the
pharmaceutical industry, this research contributes to the overall knowledge of return-on-
education modeling in a new and under-studied market. In addition, this research
presents insight into the potential of a new model for assessing value of investment into
educational initiatives worthy of consideration by academics, the medical profession,
industry professionals, and other key stakeholders.
As a result of this particular study the CHE department of an international
subsidiary of a pharmaceutical company is currently implementing an adapted version of
the pre-post questionnaire of this ROEV model and scorecard into CHE offerings.
Furthermore the ROEV model has been further adapted for the needs of other areas of the
organization for similar but different approaches to measuring 'value-added' initiatives.
Unlike the ROEV model, which relies on mostly participants' perceptions and input, the
other approaches rely purely on the input from those carrying out the initiative to provide
their best judgment on pre-specified 'value' targets to evaluate the associated outcomes.
This is different than the ROEV model, which was developed primarily to help define,
assess and improve the overall value of the organizations' sponsored educational
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initiatives. This model can be thought of as a starting place in an aim to demonstrate the
value of CHE. Clearly, more studies such as this are needed to further develop and refine
models of calculating the value of educational programs.
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APPENDIX 1 CONSENT FORM TO PARTICPATE IN RESEARCH
This is to state that I agree to participate in research conducted by Jenna Momy of the
Continuing Health Education Department of Pfizer Canada Inc. and student at
Concordia University.
A. PURPOSE
I have been informed that the purpose of the research is to assess a continuing health
education program and develop an assessment method for future programs.
B. PROCEDURES
The participant will be asked to fill in a pre-test questionnaire as well as a post test
questionnaire when attending a CHE event.
Furthermore a representative will follow up with a questionnaire to be discussed 1
month after the activity.
C. CONDITIONS OF PARTICIPATION
• I understand that I am free to withdraw my consent and discontinue my
participation at anytime without negative consequences.
• I understand that my participation in this study is confidential, anonymous at
my discretion.
• ¡understand that the results of this study may be published.
I HAVE STUDIED THE ABOVE INFORMATION AND UNDERSTAND THIS
AGREEMENT. I FREELY CONSENT AND VOLUNTARILY AGREE TO





Ifat any time you have questions about your rights as a research participant or care to
know more information on this research project, please do not hesitate to contact Adela
Reid, Research Ethics and Compliance Officer at Concordia University, at 514-848-
2424 x7481 or by email at adela. reid@Concordia.ca
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APPENDIX 2: PRE- / POST-CHE EVENT QUESTIONNAIRE






Facilitator's Name: [INSERT FIELD]
Organizer's Name: [INSERT FIELD]
Date of Session: [INSERT FIELD]







Preferred method of contact:
All information collected in this survey will remain strictly confidential to Pfizer
Continuing Health Education & Development Department. Your personal identity
will not be revealed and will never be linked to the answers you provide.
Participation in the survey is completely voluntary. Your identity will not be
disclosed in any subsequent reports or publications that result from the study.














0.2 Years Experience in Current
Role




0.3 Type of Practice
Q Solo (one healthcare provider)
? Group (two or more healthcare
providers)
0.4 Setting






0.5 Location of Practice
? Urban - > 500,000
? Suburban - 100,000 - 500,000
? Rural -< 100,000
0.6 How were you informed about this program?
? Colleague
? Journal advertisement
? University or university publication
? Professional association











The following statements and questions seek to evaluate what you expect to
gain by participating in the INSERT FIELD] program. Please consider each
statement and respond as indicated on the scale provided.
IMPORTANCE OF LEARNING OBJECTIVES
1.1. Please review each learning objective listed below and
rate its importance to you to your clinical practice. Circle the
appropriate number on the 5-point scale, from 1 (Very






1.2.Consider the following statements about the knowledge
you expect to gain from this program. Please indicate the
extent to which you agree with these statements on the 5-
point scale, from 1 (Strongly Disagree) to 5 (Strongly Agree).
The topic of this program is highly relevant to my clinical
practice
II. The topic of this program is unrelated to my practice
III. I anticipate that the knowledge I will gain from this program
will improve my clinical practice
IV. I believe I have patients who will benefit from my increased
knowledge about this topic
Very Not
lmportantlmportanfl
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
Strongly Strongly
Disagree Agree
PERCEIVED IMPACT ON PRACTICE
1.3.The following questions relate to your intent to apply the
knowledge you hope to gain in this program to your clinical
practice. Please review these questions and rate how much
you intend to apply the knowledge on the 5-point scale, from
1 (Very much) to 5 (Not at all).
To what extent do you think you will apply what you will
learn in this session to the treatment of your patients in
your clinical practice
II. Have you considered how you will implement changes inyour treatme t of patients follo ng this program
How confident are you that you will apply what you will
learn in this program to the treatment of your patients
12 3 4 5
12 3 4 5
12 3 4 5





12 3 4 5
12 3 4 5
12 3 4 5
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PROGRAM ORGANIZATION
1.4. Please tell us about the setting and organization of this
program. Rate the extent to which you agree with the
following statements as factors that attracted to you to this
program on the 5-point scale, from 1 (Strongly Disagree) to 5
(Strongly Agree). Strongly Strongly
Disagree Agree
Setting will be appropriate for learning 12 3 4 5
II. Length of program will be appropriate 12 3 4 5
III. Facilitator/key speakers) is credible 12 3 4 5
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Post-CHE Event Questionnaire
The following statements and questions seek to evaluate your experience in
participating in the INSERT FIELD] program. Please consider each statement
and respond as indicated on the scale provided.
IMPORTANCE OF LEARNING OBJECTIVES
2.1 Please review each learning objective below and rate the
importance to your clinical practice of what you learnt
today. Circle the appropriate number on the 5-point scale,







2.2 Consider the following statements regarding the
knowledge you gained from this program. Please indicate
the extent to which you agree with these statements on




I. The topic is highly relevant to my clinical practice
II. The topic of this program is unrelated to my practice
The knowledge I gained from attending this program will
improve my clinical practice
IV. I have patients who will benefit from my increased
knowledge about this topic "
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
Strongly Strongly
Disagree Agree
PERCEIVED IMPACT ON PRACTICE
2.3 The following questions relate to your intent to apply the
knowledge you hope to gain in this program to your
clinical practice. Please review these questions and rate
how much you intend to apply the knowledge on the 5-
point scale, from 1 (Very much) to 5 (Not at all).
To what extent do you think you will apply what you
learned in this session to the treatment of your patients in
your clinical practice ____—^-
12 3 4 5
12 3 4 5
12 3 4 5





12 3 4 5
II. Have you considered how you will implement changes in
your treatment of your patients following this program
III. How confident are you that you will apply what you




2.4Think about your clinical practice and the barriers or
obstacles you might encounter in putting the new
knowledge you gained today into practice. Please rate the
importance of the potential barriers listed below in
preventing you from applying what you learnt from this
program using the 5-point scale provided, from 1 (No
barrier) to 5 (Major barrier).
I. Lack of experts to consult with in applying new
knowledge with my patients
II. Lack of accessibility to follow up materials to reinforce my
changing my practice
III. Lack of necessary equipment to apply new knowledge
gained
IV. Lack of time to implement new practices
V. Lack of financial resources to implement new practices
VI. Other. Please Specify
PROGRAM ORGANIZATION
2.5 Please tell us about the setting and organization of this
program. Rate the extent to which you agree with the
following statements on the 5-point scale, from 1
(Strongly Disagree) to 5 (Strongly Agree).
Setting was appropriate for learning
II. Length of program was appropriate
III. Facilitator/key speakers) was credible





Program content was credible and unbiased
Information was presented clearly
Speaker was knowledgeable and was familiar with the
content





12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
Strongly Strongly
Disagree Agree
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
2 3 4 51
12 3 4 5
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APPENDIX 3: RETURN ON EDUCATIONAL VALUE FOR CHE&D
FOLLOW-UP INTERVIEW GUIDE
Return on Educational Value for CHE&D
• Follow-up Interview Guide




• terns in Italics are for CHE Champion to respond based on reflection
of HCP input and feedback
3.1 Was the program content credible and unbiased?
3.2.1 Were the knowledge and skills presented in this
program useful?
3.2 2 CHE Champion perception ofHCP knowledge gain
3.3.1 Did anything in the program make you change your
current practice?
3.3.2 CHE Champion perception of intent of HCP tochange practice
3.4.1 Are you doing anything differently as a result
of what you learned in this program?
3.4. 2 CHE Champion perception of HCP practicechange
3.5 Is there any way that I can help you in
providing care to your patients? Information?
Research? Guidelines? Tools? Networking
contacts?
3.6 Change in scope of discussion between HCP
and CHE Champion
¦ Increase in requests for information,
samples, interaction
¦ Change in tenor of discussion - more open,
more friendly
3.7 Increased time for CHE Champion
¦ Frequency
¦ Length of visit
¦ Prioritization of Pfizer CHE Champion overReps from other companies
Not at all· Very Much
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
Open Field
12 3 4 5
3.8 Did you have a chance to ask questions and speak
with other healthcare professionals attending the
program?
3.9.1 What stops you from implementing what you
learned the way that you would like to?
3. 9. 2 CHE Champion perception of HCP barriers topractice change
3. 10 What do you think about the program?
3.1 1 Do you see patients who can benefit from the
program? ??
3.12 Have you seen any improvement in the impact of
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
Open Field
12 3 4 5
12 3 4 5
12 3 4 5
12 3 4 5
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your treatment and management of [FIELD] as a
result of your attending this program?
3.13 Would you suggest (this program) to yourcolleagues? 12 3 4 5













































































Relevance to Practice -
The topic of this
program is highly



















Relevance to Practice -
The topic of this






























































Relevance to Practice -





















Practice - To what -
extent do you think
you will apply what you
will learn in this
session to the
treatment of your
























confident are you that
you will apply what you









































2.4.1. Post-program Barriers to Application - Lack of experts to consult with in applying















2.4.11. Post-program Barriers to Application - Lack of accessibility to follow up materials




















































































































































































































































































































































































































































2.5. VII. Post-program Program
Organization · Speaker was
knowledgeable and was














Confidence Level(95.0%) . 0.063779
2.5.VIII. Post-program Program
Organization - Adequate
opportunity was provided for
interaction and questions with

















One Month Follow Up - Descriptive Statistics
Relevance to Practice/Perception of Knowledge Gain






































































































































































































































































































Perception of Impact on Patient Outcomes
3.13 Have you seen any improvement in the impact of your treatment and management of



































































Interaction between CHE Champion and Participant



































































3.5 Is there any way that I can help you in providing care to your patients?




































































































§ Change in tenor of discussion - more open, more friendly
Mean
Standard Error
3.588235294
0.158635262
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Median 3
Mode 3
Standard Deviation 0.92499458
Sample Variance 0.855614973
Kurtosis -0.862718939
Skewness 0.213683684
Range 3
Minimum 2
Maximum 5
Sum 122
Count 34
Largest(1) 5
Smallest(1) 2
Confidence Level(95.0%) 0.322745865
